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Musculoskeletal anomalies are a heterogeneous group of fairly common, often with severe 
clinical symptoms, but mostly fatal disorders in human and animals. By far, complex vertebral 
malformation (CVM) and Brachyspina are the most important lethal osteodysplasias described 
in Holstein Friesian (HF) cattle. First aim of this thesis was to elucidate the genetic cause of a 
lethal case of osteogenesis imperfecta (OI) in a newborn HF calf. The molecular mechanism 
underlying OI in humans has been clearly explored, with a series of candidate genes reported. 
However, none of these hitherto known genes harboured any causative variant in the affected 
OI calf. To identify genomic regions associated with OI, a genome wide association study was 
performed. A total of 6 significantly associated SNP loci were detected on 1, 5, 6, 17, 18, and 
24 (p < 0.05). In addition, a whole genome re-sequencing of the affected calf and its parents as 
well as gene prioritization using CANDID was performed. From these analyses 16 candidate 
genes with functional variants remained. Validation was performed in 2612 randomly chosen 
healthy German HF using high-resolution melting curve analysis. Finally, a haplotype of 4 
functional variants in 3 candidate genes (ABCA13: ENSBTAT00000061018.2:c.12553+1A>G, 
p.Gln4393Arg; QRFPR: p.Arg412Ter; IFITM5: p.Ala30Ser) was determined explaining the 
development of OI in the calf. This was in agreement with the results of the GWAS indicating 
a so far unknown oligogenic origin of OI. 
 
Bovine interdigital hyperplasia (IH) is a typical claw disorder affecting cattle welfare and 
causing serious economic losses. IH shows the highest estimated heritabilities in comparison to 
other feet/claw disorders. Second aim of this thesis was to elucidate the molecular genetic cause 
of IH in HF. To investigate the pathogenesis, the IH status was inspected during hoof trimming 
of first-lactation dairy cows. To study the clinical course, the cows were examined seven times 
every three months. From herds with highest IH prevalence, cows were selected to perform a 
genome-wide association study. Two significantly associated chromosomal positions were 
revealed with both located in the tyrosine-protein kinase transmembrane recepetor ROR2 gene. 
Due to its previously reported function, ROR2 was a reasonable candidate for IH. A 
comparative sequencing between cases and controls was conducted and 2 missense mutations 
were identified. Large-scale genotyping showed that one variant ROR2 p.Trp9Arg was highly 
significantly associated with IH (p < 0.0001). Quantification of mRNA and protein levels 
proved significant reduction of ROR2 expression due to this variant. 
 
Ribosome biogenesis is the process of generating ribosomes which serve as the site of 
biological protein synthesis in all living cells. Impaired or decreased ribosome biosynthesis is 
associated with a group of diseases called ribosomopathies. Due to the lack of functional 
ribosomes, these diseases broadly fall under the category of cellular hypo-proliferation 
phenotypes. Before supportive care was developed, such hypo-proliferation phenotypes were 
severe even lethal in the past. Molecular dissection of ribosomopathies in humans has revealed 
 vi 
a list of causal genes, however, ribosomopathies have not been reported in cattle so far. Third 
aim of this thesis was to address the question whether lethal variants in the causal genes of 
ribosomopathies exist in cattle. A 2bp deletion has been deposited into bovine genomic 
databases in bovine uL5 gene on chromosome 2, which would result in a frameshift and a 
premature stop codon. The deletion causes a truncation of bovine uL5. A probe for this variant 
had been included as expert-selected marker in the custom add-on part of the Illumina 
BovineLD BeadChip and can therefore be monitored during routine genotyping. To determine 
the frequency of the variant, we genotyped 370,527 cattle, including 18 different dairy and beef 
cattle breeds. 299,218 homozygous wild type and 71,249 heterozygous cattle were called from 
the bead chip. Cattle harboring the homozygous mutant genotype were not detected. According 
to Hardy-Weinberg equilibrium around 4,241 homozygous individuals carrying the deletion 
should have been present in the cohort. Hence, the data apparently indicated that the 
homozygous 2 bp deletion in uL5 was a lethal variant interfering with ribosome biogenesis and 
resulting in embryonic death. However, using Sanger sequencing we could not detect the 
putative deleterious variant in randomly selected heterozygous cattle identified by the 
BeadChip genotyping. An alignment of the BeadChip probe to the bovine genome showed a 
perfect match to a processed uL5 pseudogene on bovine chromosome 18 mimicking the 
assumed exonic deletion. Subsequently, an examination by Sanger sequencing showed that the 
previously detected heterozygous cattle were homozygous for the 2 bp deletion within the 
pseudogene. The BeadChip genotyping results were clearly confounded by the erroneous 
detection of this variant. Therefore, special care should be taken when designing probes and/or 
primers for a specific assay in high-throughput genotyping platforms to avoid severe 
misinterpretations led by pseudogenes. We not yet identify a lethal variant, however, our 
strategy can be used to farther explore potentially recessive lethal variants causing 
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1 Osteogenesis imperfecta 
1.1 Complexity and dynamic nature of bone tissue 
Bone is a mineralized tissue, exerting important functions in the body, such as structural support 
for the body, protection of vital organs, harboring of bone marrow, and minerals storage. Bone 
comprises two main tissue types on the macroscopic level: cortical bone and trabecular bone 
[1]. Cortical bone tissue also called compact bone, is a dense, hard and rigid outer layer of bone. 
In contrast, the inner layer is light and spongy-like, called cancellous or trabecular bone. There 
are four types of cells in bones, i.e. osteoblasts, osteoclasts, bone lining cells and osteocytes, 
responsible for bone formation, maintenance, modeling as well as remodelling [1]. 
1.1.1 Osteogenesis and bone growth 
Osteogenesis is the process generating new bone substance. Bone is formed mainly in two ways 
[1]. Intramembranous ossification involves the replacement of mesenchymal tissue with bone 
in embryogenic processes, resulting in the formation of skull and some facial bones [2]. The 
formation of the majority of other bone tissue, such as femur, humerus and many other kinds 
of long bones originates from endochondral ossification. It involves the initial generation of a 
hyaline cartilage intermediate, which is afterwards converted into bone by bone forming cells 
- osteoblasts [2]. 
 
The majority of limb bones feature long bone characteristics [3]. Each long bone comprises two 
extremities and one shaft, with length wider than width. Long bone contains compact bone 
substance in outside layer, medullary cavity insides, as well as spongy bone and an epiphyseal 
line at ends. During the whole childhood and adolescence, long bone keeps growing in width 
and length. Increase in length relies on hyaline cartilage in epiphyseal line, which continues 
forming bone at the ends of long bones in endochondral ossification model [4]. In contrast, 
accumulation in width of long bones is attained by forming new bone substance on the outside 
of the compact bone type. 
1.1.2 Bone remodeling 
Once bone formation is completed in adulthood, the only mode to replace old bone substance 
with new tissue is via bone remodeling. This complex mode remains active until death to 
maintain mineral homeostasis and bone strength [3]. This also enables self-heal processing of 
bone microdamages and skeleton recovery from mechanical use [5]. One bone remodeling 
cycle consists of three phases: (i) initial removal of mineral matrix of old bone by actived 
osteoclasts, (ii) reversal process from resorption to new-synthesized proteinaceous matrix, (iii) 
matrix mineralization to generate new bone substance by osteoblasts [6]. This cycle relies on 
close cooperation of osteoclasts, osteoblasts, as well as bone lining cells and osteocytes, which 
are organized in a temporary anatomical body, known as basic multicellular unit (BMU) [7]. 
Bone mass and integrity depend on maintenance of a delicate balance between bone resorption 
by osteoclasts and bone formation by osteoblasts [8]. Osteocytes act as orchestrators in bone 
remodeling process through regulation of both osteoclast and osteoblast activity [9]. Bone 
lining cells play an essential role in coupling bone resorption to bone formation by removal of 




An imbalance of bone resorption and formation leads to various bone diseases. For instance, 
defects in osteoclast formation and function cause increased bone mass and osteopetrosis [11]. 
Whereas excessive bone resorption by osteoclasts contributes to osteoporosis and 
corticosteroid-induced bone loss [12-14]. In addition, emerging evidences in human patients 
reveal the relevance of abnormal genes/proteins important for osteoblast differentiation and 
mineralization with osteogenesis imperfecta [15]. 
1.2 Phenotypic aspect of osteogenesis imperfecta 
1.2.1 Clinical introduction 
Osteogenesis imperfecta (OI), also called “brittle bone disease”, is a genetically 
heterogeneous skeletal dysplasia, affecting about 1 in 10,000 to 20,000 live births in humans 
[16, 17]. OI patients are characterized by a prominent skeletal phenotype, with widely varying 
clinical severity. Also, joint laxity, scoliosis, dentinogenesis imperfecta and craniofacial 
abnormalities may be present in patients with OI; other extra-skeletal manifestations include 
hearing impairment, blue or gray sclerae, lung abnormalities, and hypercalciuria for instance 
[17-20]. 
 
The earliest OI case reported was dated to circa 1000 BC. After reconstruction of the skull of 
the Egyptian mummy, paleopathologists were convinced of an OI affected infant, because of 
its deformity of vertical axis and transverse axis bones as well as deformed dentition [21]. The 
first scientific description about OI was supplied by Olaus Jakob Ekman in 1788, in the ‘
congenital osteomalacia’ thesis [22]. The hereditary fragile bone disease occuring in three 
generations of a family was introduced to medical expert knowledge [22]. Afterwards, various 
terms were used to characterize familial skeletal fragility. Until 1849, the phrase ‘osteogenesis 
imperfecta’ (in Dutch: gebrekkige beenwording) was first-time introduced by Willem Vrolik, 
a professor from Amsterdam University [23]. By stating that the primary impairment of 
ossification already existed in the specimen, he realized that various skeletal dysplasias may be 
caused by insufficient intrinsic ‘generative energy’, but not the result of a postnatally 
acquired disorder [23]. 
 
In 1974, by scanning electron microscopy of bone collagen in 3 congenital OI patients, 
abnormalities of bone collagen aggregation from thin collagen fibers into extracellularly large 
collagen fiber bundles of bone were described [24]. The organizational alterations may partially 
explain the changes in physical properties leading to the frequent fractures featuring this disease 
[24]. Using pepsin digests of skin of OI patients an increased ratio of the alpha 1 (III) to alpha 
1 (I) chains from two kinds of collagen type III and type I was identified [25]. This increased 
ratio may be due to a reduction of type I collagen [25]. These findings set the basis to clarify 
molecular and pathogenic mechanisms of OI. 
1.2.2 Classification 
Increasing OI cases have clarified in detail that OI represents a bone disease with clinical 
severity remarkablely varying from perinatal lethality to slightly increased fracture frequency. 




Australia, ‘Sillence classification’ was introduced in 1979 to further classify this disease and 
became the basis of current classification and severity verification of OI [19]. 180 OI cases 
were verified and studied in epidemiological and genetic aspects. According to their clinical 
phenotypes and inheritance modes the OI cohort was classified into at least four different 
syndromes. The first group, with autosomal dominant inheritance, showed osteoporosis and 
consequently fractures as well as blue sclerae [19]. The second group, with perinatal lethality, 
showed beaded ribs as well as broad and crumpled femora. Some cases in this group showed 
autosomal recessive inheritance [19]. The third group, comprised sporadic OI cases, 2/3 of them 
showed fractures at birth, and had severe progressive deformity of spine and limbs. The 
inheritance pattern in this group could not be clarified. But it was stated that this group could 
be heterogeneous with both recessive and dominant inheritance [19]. In the fourth group, 
patients were characterized by dominantly inherited osteoporosis resulting in fractures, with 
variable deformities in long bones but normal sclerae [19]. In 1984, Sillence et al. subdivided 
the second group (OI type II) into three groups (A, B, C) based on the differences of the clinical 
and radiological findings [27]. In the cases of group A, ribs were short and thick with continuous 
beading, femora appeared broad and crumpled, and tibiae were angulated [27]. In group B, long 
bones and skull were similar in appearance to those of group A patients, but ribs were normal 
or showed incomplete beading [27]. In group C, cases had slender beaded ribs. The shafts of 
the long bones showed acute angulation deformities with multiple fractures [27]. 
 
In 2004, Rauch and Glorieux expanded the original Sillence classification to 7 distinct types 
[18]. Until then, mutations in COL1A1 and COL1A2 genes, which encode α1 and α2 chains of 
the collagen type I respectively, were found in all the four types of OI [18]. OI types V–VII 
were added without defining specific genetic reasons [18]. However, OI type V was presumed 
to be inherited in an autosomal dominant pattern, while type VI and VII were supposed to be 
autosomal recessively inherited, with significantly different typical features [18]. 
 
In 2006, the first genetic reason of recessive OI type was reported, i.e. CRTAP mutations [28]. 
Since then, more and more genetic causes of OI have been reported, although COL1A1 or 
COL1A2 mutations were still responsible for the majority of OI cases. There was some debate 
in literatures on how to incorporate this newly identified OI heterogeneity into the classification 
system. Some researchers proposed to designate the OI caused by recessive mutations in PPIB 
as OI type IX [29], SERPINH1 missense variants as OI type X, and FKBP10 frameshift variants 
as OI type XI [30]. However, another viewpoint was proposed by van Dijk and his colleagues, 
since the newly defined OI types base on different causative gene mutations resulted in a 
confusing OI classification [31]. They proposed to exclude type VII and VIII [31]. These types 
were added due to genetic criteria, but their clinical and radiological features were not 
distinguishable from types II-IV [31]. Besides, Bruck syndrome manifested clinically with a 
combination of classical osteogenesis imperfecta and multiple congenital joint contractures, 
which arised the debate about whether this syndrome should be classified as a subtype of OI 
[32]. 
 
Finally in 2011, the International Nomenclature group for Constitutional disorders of the 




into 5 types [33]. It retainied the original 4 types from the Sillence classification and amended 
by the addition of the OI type V, defined as osteogenesis imperfecta with calcification of the 
interosseous membranes and/or hypertrophic callus [33]. The importance of the various genetic 
reasons of the OI types was acknowledged through encapsulating them separately as subtypes 
of the OI type I to V [33]. Bruck syndrome was not classsified into any of OI types I-V [33]. 
Forty years ago, Sillence proposed the first systematic classification based on clinical features. 
Today it is clear that OI is a disorder with a greater heterogeneity than previously thought. It is 
necessary to consider correlations between the proposed clinical types and the 
genetic/molecular findings. 
1.3 Molecular dissection of osteogenesis imperfecta 
1.3.1 Genetic heterogeneity and mechanisms in humans 
Collagen synthesis 
Almost 90% of OI cases are caused by dominant mutations in either COL1A1 or COL1A2, 
encoding the α1 and α2 chains of type I collagen, respectively [18, 34]. Collagen is a fibrous 
protein that is part of connective tissues. Collagen I is a heterotrimer composed of two α1 and 
one α2 polypeptide chains, which form a triple helix. Each chain contains hundreds of 
uninterrupted repeats of the Gly-X-Y triplet, where X and Y can be any amino acid but are 
often proline and lysine. The latter residues are commonly hydroxylated by specific proline or 
lysine hydroxylases, which protects the triple-helical structure from melting at normal body 
temperatures [35]. The conserved glycine occurs in every third position, since it is the only 
amino acid residue that fits sterically in the core of the triple helix without disrupting the 
structure. 
 
There are mainly two types of collagen I variants resulting in OI, one type resulting in a normal 
structure but an altered quantity of type I procollagen, another type leading to a structurally 
aberrant protein [34]. Quantitative defects are usually the result of nonsense and frameshift 
variants throughout most part of the COL1A1/COL1A2 gene causing premature termination of 
translation and hence a significant reduction in the amount of transcript from the mutant allele 
[36]. Those result in haploinsufficiency of type I collagen and are commonly seen in mild or 
moderate forms of OI [36, 37]. Qualitative defects are commonly caused by variants impairing 
triple helix formation, e.g. splice site variants causing in‐frame exon skipping resulting in 
shorter alpha chains [34]. Qualitatively altered collagens are commonly seen in more severe or 
lethal forms of OI [34, 38]. 
 
The functional importance of type I collagen gene COL1A1 and COL1A2 for osteogenesis have 
also been proved in mouse models. The COL1A1Mov13 mouse has been generated with a 
transcription blockage in the murine COL1A1 gene [39, 40]. Mice embryos carrying this variant 
in a homozygous manner (Col1a1Mov13/Mov13) display degenerated development and prenatal 
lethality [39, 40]. The Aga2 (abnormal gait 2) mice have been created to carry a frameshift 
mutation in the C-terminal end of COL1A1 gene [41]. Aga2 heterozygous animals (Aga2+/−) 
have obviously increased bone turnover and a disrupted collagen network [41]. Also, the mice 




disfunctions [41, 42]. The BrtlIV mice carry a heterozygous substitution from glycine to 
cysteine at amino acid p349 of COL1A1 [43]. BrtlIV mice display a phenotypical variability in 
severity ranging from moderate forms to perinatal lethality [43]. They also exhibit the classical 
OI phenotype, i.e. deformity, fragility, osteoporosis as well as disrupted trabecular structure 
[43]. The Oim mice carry a G deletion at nucleotide 3983 of the COL1A2 gene, resulting in the 
sequence alteration of the last 48 amino acids [44]. The mutation results in accumulation of 
al(I) homotrimeric collagen in skin and bone tissues, and a deficiency of the pro-α2(I) collagen 
chain [44]. Phenotypes observed in the homozygous mice (Oim−/−) include susceptibility to 
skeletal fractures from a young age, limb deformities, generalized severe osteopenia and small 
body size [44]. Histologically, their bones show decreased enzymatic cross-links and increased 
nonenzymatic cross-links of collagen, smaller mineral crystals with more variable orientation 





Fig. 1 Molecular overview of osteogenesis imperfecta 
(Modified based on the figure by Dr. Namrata Chhabra [48]) 
Collagen processing 
Bone morphogenetic protein 1, also called mammalian tolloid protein, is an astacin 
metalloprotease encoded by BMP1 gene [49, 50]. BMP1 was initially demonstrated as the type 
I procollagen C-proteinase [51]. It cleaves the COOH-propeptides from procollagens I–III to 




N- and C-propeptides of procollagen is a crucial step in collagen fibril formation [52]. 
Especially, the removal of the C-propeptides triggers the self-assembly of collagen monomers 
into fibrils [52]. Type I procollagen C-propeptide cleavage site variants were identified in two 
OI patients with high bone mineralization density [53]. The report demonstrates that 
procollagen C-propeptide cleavage plays a crucial role in normal bone mineralization [53]. In 
humans, homozygous or heterozygous BMP1 variants have been identified as causes of OI with 
bone fragility and frequent fractures [15, 54-58]. Most of these BMP1 variants have been 
proved to be associated with impaired procollagen type I C-propeptide cleavage [55-57]. 
 
There are four secreted mammalian BMP1-like proteinases, i.e. BMP1, mTLD, mTLL1 and 
mTLL2, involved in processing of procollagen I C-terminal propeptide with varying cleavage 
efficiency. BMP1 has the highest protease activity in early developmental stages [59, 60]. Lysyl 
oxidase catalyzes the oxidative deamination of lysine and hydroxylysine residues in collagen 
and peptidyl-lysine in elastin precursors to form semialdehyde residues. Then the aldehydes 
undergo nonenzymatic reactions leading to the cross-linkages known to be critical in the 
generation of elastin and collagens in extracellular matrix biosynthesis [61]. BMP1/TLD-like 
proteases have also been reported to be responsible for the main processing resulting in the 
activation of lysyl oxidase [62]. 
Prolyl 3-hydroxylase complex  
Proteins CRTAP, P3H1 and CypB assemble in a 1:1:1 ratio to form the endoplasmic reticulum-
localized collagen prolyl 3-hydroxylation complex. The variants disrupting the expression of 
any protein in this complex have been reported to cause recessive OI [63-65]. Analysis on the 
OI cases has discovered the 3-hydroxylation function of the prolyl 3-hydroxlyation complex at 
proline residues in the helical region of type I procollagen, Pro707 of chain α2(I) and Pro986 
of chain α1(I) [66]. But the biological importance of this collagen 3-hydroxylation modification 
is not clear so far. In addition, the P3H1-CRTAP-CypB complex acts as a collagen chaperone, 
by interacting with triple helical collagen [67]. 
 
CRTAP acts as the helper protein of the complex and is mutually stabilized by P3H1 in the 
collagen prolyl 3-hydroxylation complex [68]. CRTAP is expressed in the skeleton by growth-
plate proliferating chondrocytes, cells joining cartilage and bone, osteoblasts and -clasts, as well 
as other cells to varying degrees [69]. In addition to the function in the ER complex, this protein 
can be secreted from cells into matrix and exerts multiple functions [68, 70]. The Crtap-null 
mice showed multiple abnormalities of connective tissue, decreased mechanical integrity of 
skin as well as renal and lung defects [71]. Emanating from these functional insights in murine 
models, CRTAP deficiency in humans is associated with recessive OI ranging from type II 
(neonatal lethal cases) to type VII (mild phenotype) [63]. Most of the reported CRTAP variants 
resulted in frameshifts or alternative splicing leading to nonsense-mediated decay and absence 
of CRTAP protein [72]. Lack or reduction of α1(I) Proline-986 hydroxylation near the carboxyl 
end of collagen have been revealed in lethal or severe OI patients with recessive CRTAP 
deficiency [28]. They do not have a primary collagen defect but have excess post-translational 
modification of collagen [28]. This suggests that prolyl 3-hydroxylation of type I collagen is of 




P3H1, is encoded by the LEPRE1 gene and provides the enzymatic component of the complex. 
It is the only component containing a Lys-Asp-Glu-Leu (KDEL) ER-retrieval sequence at the 
carboxyl terminus [73]. P3H1 was first isolated as a novel matrix chondroitin sulfate 
proteoglycan [74]. Tissue specific prolyl 3-hydroxylase gene expression in embryonic and adult 
tissues indicated its developmental role [75]. The most common LEPRE1 variant for recessive 
OI is a West African founder mutation introducted through the Atlantic slave trade [76]. Most 
of the reported LEPRE1 variants led to premature termination codon causing RNA decay. A 
novel variant resulting in a defect in KDEL caused a non-lethal OI demonstrating the KDEL 
ER-retrieval sequence is of importance for P3H1 functionality in vivo [77]. 
 
CypB, the third protein of the collagen 3-hydroxylation complex, is encoded by the PPIB gene. 
Peptidyl prolyl cis-trans-isomerization is the rate limiting step in the folding of the collagen 
triple helix, and CypB was thought to be the unique collagen peptidylprolyl isomerase for a 
long time [78, 79]. CypB levels are independent of null mutations in either CRTAP or LEPRE1 
[68]. Heterozygous variants in PPIB lead to OI type IX [80]. Collagen-directed biochemical 
studies of the few reported patients with PPIB defects showed inconsistent results. Two cases 
with PPIB variants causing moderately severe OI have normal levels of collagen α1(I) Pro986 
3-hydroxylation [29]. Two lethal cases of CypB deficiency had 30% α1(I)Pro986 3-
hydroxylation with the overmodification of the collagen helix [65, 81]. A PPIB knockout mouse 
model clarified this inconsistencies in humans and revealed the major funtions of protein CypB 
in the regulation of collagen biosynthesis and post-translational modification [79]. Specifically, 
the absence of CypB leads to cell- and tissue-specific dysregulation of collagen hydroxylation 
and glycosylation, which is independent of impaired collagen folding [79]. The reduced 
hydroxylation of specific helical lysine residues in collagen influences intermolecular 
crosslinking and fibrillogenesis, which helps to maintain the mechanical properties of the bone 
tissues [79]. 
Lysyl-hydroxylase complex and collagen chaperones 
Lysyl hydroxylase 1-3, encoded by PLOD1-3, respectively, catalyze the conversion of lysine 
to 5-hydroxylysine residues in the α-chains of procollagen. Some of the hydroxylysine residues 
are used as substrates by the lysyl oxidases family to form certain covalent cross links. 
Additionally, hydroxylysine can be used as an attachment site for carbohydrates, leading to 
galactosylhydroxylysine or glucosylgalactosylhydroxylysine [82]. Lysyl hydroxylases require 
the formation of dimers for activity. For Lysyl hydroxylase 2, FKBP65 contributes to the 
dimerization [82]. 
 
LH2 contains a short splice form LH2a and a long splice form LH2b. LH2b contains an 
additional exon 13A encoding 21 amino acids and is mainly present in tissues rich in fibrillar 
collagens, while LH2a mostly does not exist in these tissues [82]. LH2b is a telopeptide lysyl 
hydroxylase and plays an important role in the generation of collagen telopeptide-derived 
pyridinoline cross-links [82]. In humans, variants in PLOD2 have been reported to cause 
recessive form of OI as well as Bruck syndrome type 2 [83, 84]. The variants are predominantly 





FKBP65, encoded by FKBP10, affects lysyl hydroxylation indirectly. FKBP65 belongs to the 
family of FKBP-type peptidyl-prolyl cis-trans isomerases and is a rough endoplasmic reticulum 
resident protein. FKBP65 participates in folding of type I procollagen as an important molecular 
chaperone-like protein. Some recessive OI cases and Bruck syndrome type 1 are caused by 
variants of FKBP10 [86-89]. Interestingly, all variants of FKBP10 are associated with a 
phenotype that overlaps with Bruck syndrome type 2 [90]. Both syndromes display a similar 
biochemical defect that is an intense underhydroxylation of the telopeptides of collagen type I 
[82]. Specifically, FKBP10 variants indirectly affect procollagen maturation, by ablating the 
support of FKBP65 for collagen telopeptide hydroxylation by LH2, thereby reducing collagen 
cross-linking formation in tendon and bone matrix [87, 91]. Contractures and bone fractures 
are a variable manifestation of null/missense FKBP10 variants [87, 91]. 
 
As reported, FKBP65 does not form complexes with LH1 or LH3, but only with LH2. Both 
depletion of FKBP65 and inhibition of FKBP65 PPIase activity does not affect the binding of 
monomeric LH2 to procollagen Iα1, but decrease the dimeric form of LH2. Since monomeric 
LH2 is inactive and only dimeric form of LH2 shows lysyl hydroxylase activity, this explains 
why variants in FKBP65 have such a significant effect on LH2 [92]. Also, CypB can interact 
with LH2, as well as with LH1, LH3 and the putative LH2 chaperone FKBP65 [93]. CypB 
regulates collagen cross-linking by differentially influencing the lysine hydroxylation in the 
telopeptidyl and helical domains of tendon collagen type I [93]. 
 
HSP47, another chaperone for collagen, is a member of the serpin superfamily of serine 
proteinase inhibitors encoded by SERPINH1 gene. The expression of this protein is induced by 
heat shock. It preferentially binds to the N-terminus of the triple helical procollagen, stabilizes 
the folded collagen in the endoplasmic reticulum and shuttles properly folded collagen into cis-
Golgi [94]. Hsp47−/− mouse embryos die before 11.5 days post coitus, showing ruptured blood 
vessels and aberrant epithelial tissue due to defects in collagen biosynthesis [95]. Hsp47−/− cells 
have high aggregation of type I collagen in the endoplasmic reticulum, delayed secretion, 
deficience in N-propeptide processing of type I collagen and abnormal fibrillogenesis [96]. The 
first SERPINH1 variant (p.L326P) was identified in Dachshunds with OI [97]. Another case 
with severe recessive OI in humans was caused by the homozygous missense variant of 
SERPINH1 (p.Leu78Pro) [98]. 
Collagen secretion and endoplasmic reticulum stress 
Proper conformational change in endoplasmic reticulum is necessary for a newly synthesized 
protein before its secretion. Excessive protein synthesis or protein misfolding can give rise to 
endoplasmic reticulum-stress and trigger the unfolded protein response. A few recessive OI 
genes, CREB3L1, MBTPS2 and TMEM38B, have been reported probably involed in 
endoplasmic reticulum stress and unfolded protein response [15]. 
 
CREB3L1 encodes the endoplasmic reticulum-stress transducer OASIS, which is a basic 
leucine zipper transcription factor of the CREB/ATF family [99-104]. To cope with ER stress, 
it is processed by adjusted intramembrane proteolysis. This protein plays a critical role in bone 




[105]. A homozygous genomic deletion of CREB3L1 has been identified in a human family 
with severe recessive OI [106]. The knockout mice (OASIS−/−) exhibit severe osteopenia, 
spontaneous fractures, decreased cortical bones, calcaneus fracture as well as significantly 
reduced bone formation rate which are reminiscent of severe human OI [107, 108]. 
 
MBTPS2 encodes a membrane-embedded zinc metalloprotease which is located in the Golgi 
membrane and important in development. It cleaves regulatory proteins including OASIS, 
ATF6 and SREBP which are transported from the endoplasmic reticulum membrane and 
involed in the endoplasmic reticulum-stress response. Two MBTPS2 missense variants at highly 
conserved residues cause moderate/severe recessive form of OI in two independent kindreds in 
humans [109]. The mutant site-2 metalloprotease leads to impaired operating in regulated 
intramembrane proteolysis of OASIS, ATF6 and SREBP substrates and decreased 
hydroxylation of the collagen lysine residue in the proband bone tissue [109]. 
 
TMEM38B encodes the endoplasmic reticulum membrane Tric-B protein, that acts as a 
monovalent cation channel. Tric-B is ubiquitously present in most mammalian tissues [110]. 
Tric channels, including Tric-A and Tric-B subtypes, regulate Ca2+ release from intracellular 
stores [110, 111]. Tric-B knockout mice (Tric-B-/-) die shortly after birth because of respiratory 
failure [112, 113]. This demonstrates that Tric-B subtype plays an essential role in mouse 
perinatal development, in particular in Ca2+ processing of the alveolar type II epithelial cells 
[113]. Also, Tric-B knockout mice display deficient bone ossification [112]. Bone histological 
examination indicates that collagen matrix deposition is decreased in Tric-b knockout mice 
[112]. Osteoblasts of the knockout mice display lowered Ca2+ release and increased Ca2+ 
content in endoplasmic reticulum [112]. They are associated with the swelling of endoplasmic 
reticulum and also the sign of the collagen trafficking defect through endoplasmic reticulum 
[112]. Tric-B function is indispensable to support the formation and normal release of large 
amounts of collagen by osteoblasts [112]. In humans only a few autosomal recessive OI cases 
have been reported with functional variants in TMEM38B [114-118]. 
Osteoblast differentiation and mineralization 
Osteoblasts, terminally specialized and differentiated products of mesenchymal lineage cells, 
are responsible for synthesizing bone in groups of connected cells [119]. Aberrant proliferation, 
differentiation and function of osteoblasts significantly affect bone quality and quantity. After 
collagen is secreted into the extracellular matrix by mature osteoblasts, a variety of factors 
regulate the mineralization process [15]. Molecular biological studies on human OI provide 
evidence that few genes, i.e. WNT1, SP7, SERPINF1 and IFITM5, play important roles in 
osteoblast differentiation and mineralization [15]. 
 
IFITM5 (bone restricted Ifitm-like protein) is involved in bone mineralization and expressed 
most prominently in osteoblasts [120, 121]. In 2012, a heterozygous de novo variant (c.-14C>T) 
in the 5'-UTR of IFITM5 has been confirmed to be the causative variant for OI type V featuring 
hyperplastic callus development [122]. Transgenic mice overexpressing this OI type V mutant 
IFITM5 exhibited perinatal lethality, delayed or abnormal mineralization, skeletal 




novo variant (c.119C>T) resulting in an amino acid exchange p.Ser40Leu did not have typical 
signs of OI type V but exhibited limb shortening at prenatal period [124]. Analysis on Ifitm5-
deficient mice suggested that that Ifitm5 deficiency might have a greater impact on prenatal 
bone development, since the effect of Ifitm5 deficiency on bone formation was more obvious 
in neonates than in young and adult mice [121]. In the study, FKBP11 was identified to interact 
with IFITM5 by liquid chromatography mass spectrometry [121]. However, it is not clear 
whether IFITM5 also participated in protein folding and immunosuppressant binding after 
linking to FKBP11 [121]. 
 
SERPINF1 encodes PEDF a member of the serpin family. PEDF does not exhibit serine 
protease inhibitory activity displayed by many other serpin proteins. It is a secreted 
neurotrophic protein participating in neuronal differentiation in retinoblastoma cells and also 
functions as potent inhibitor of angiogenesis. In bone, PEDF has been reported to inhibit 
osteoclast function by regulating osteoprotegerin expression [125]. Therefore, PEDF plays a 
role in the maintenance of bone homeostasis [125]. Loss of function and truncating mutations 
in SERPINF1 are reported in humans with type VI and severe OI, respectively [126, 127]. 
Recessive OI type VI is uniquely characterized with an increased amount of unmineralized 
osteoid. Studies identify that PEDF is involved in bone mineralization [126]. Pedf null mice 
(Serpinf1−/−) show increased mineral deposition, decreased trabecular bone volume and brittle 
bones recapitulating key structural and biochemical bone features observed in human OI type 
VI [128]. PEDF is absent in the sera of OI type VI patients, but restored serum PEDF level by 
using HDAd vector to express SERPINF1 in liver is not able to rescue the bone phenotype 
observed in Serpinf1(-/-) mice [129]. This suggests that PEDF might function in bone 
homeostasis in a context-dependent and paracrine manner [129]. However, intraperitoneal 
injection of PEDF-containing microspheres raises bone volume fraction and enhances 
biomechanical parameters of bone plasticity in PEDF-KO mice [130]. The report also indicates 
that a conserved motif on PEDF accentuates blockade of the Wnt receptor LRP6 to allow for 
terminal osteoblast differentiation [130]. 
 
SP7/Osx encodes Osterix protein, a member of the subfamily of Sp or XKLF transcription 
factors. It represents a bone specific transcription factor and plays an essential role in osteoblast 
differentiation [131]. A homozygous deletion resulting in a frameshift mutation in Osx is 
reported in an Egyptian child with recessive OI, featuring with delayed tooth growth, mild bone 
deformities and recurrent fractures [132]. In Osx-null mice, no endochondral or 
intramembranous bone formation occur. Studies on the embryos reveal that Cbfa1 is needed for 
Osx expression [133]. In osteoblast differentiation pathway, Osx works downstream of Cbfa1 
[133]. The inactivation of Sp7 gene in mature bone causes a functional defect in osteoblasts and 
lowered bone formation [134]. The study shows that Osx is necessary to maintain osteoblast 
function following adult bone maintenance [134]. 
 
WNT1 is a member of the WNT gene family, which is composed of structurally related genes 
encoding secreted signaling proteins. WNT signaling has been implicated in bone homeostasis 
[135]. Studies in humans and mice have proved that the canonical Wnt/b-catenin signaling is 
indispensable for skeletal development and bone formation after childbirth by regulating the 




by which WNT signaling adjusts bone formation has been well documented, the critical WNT 
ligands involved in this process remain unclear. Interestingly, several studies demonstrate that 
functional variants in WNT1 cause recessively inherited OI, also heterozygous WNT1 variants 
result in early onset osteoporosis in humans [148-151]. Furthermore, mice carrying 
homozygous null alleles of Wnt1 exhibit embryonic lethality [152]. The Swaying mouse 
(Wnt1sw/sw) carries a single nucleotide deletion in the exon of WNT1 resulting in a premature 
termination [153]. It exhibits spontaneous fractures, severe osteopenia, lowered bone strength, 
compromised collagen and mineral properties as well as declined osteoblast activity [153]. 
Therefore, these reports suggest that WNT1 could be a critical ligand involved in the WNT 
signaling adjusting bone homeostasis. 
1.3.2 Genetics research progress in domestic animals 
OI has also been documented in domestic animals, including Red Angus calves [154], 
Fleckvieh cattle [155], Charolais cattle [156], lambs [157], cats [158-160] and dogs [97, 161-
163].  
 
Around 50 newborn New Zealand Romney lambs in a flock were affected with OI and skin 
fragility [157]. They also showed multiple intrauterine bone fractures, soft bones, aberrant long 
bones, brachynathia inferior, obvious joint laxity, blue sclera, small pink teeth and 
subcutaneous oedema [157]. The defective collagen production by fibroblasts was confirmed 
by histopathologic and ultrastructural analyses [157]. The disease seemed to be caused by a de 
novo mutation in the germ line of a ram of the flock and was transmitted as an autosomal 
dominant disorder [157]. 
 
In six newborn half-sib Charolais calves, a hereditary bone disease was described [156]. In 
many aspects, the findings from the clinical, pathological, radiological, and genetic studies were 
similar to the congenital OI reported in humans and sheep [156]. However, the genetic reason 
of this case has not been clarified so far. Recently, a de novo mutation in COL1A1 
(p.A1049_P1050delinsS, insertion-deletion) was described in OI type 2 in Fleckvieh cattle 
[155]. Another de novo mutation in COL1A1 (p.Gly355Ser) was identified as the causative 
variant of OI in two Red Angus calves [154]. The variant led to the substitution of a glycine 
residue with serine in the triple helical domain of the protein. In this region, glycine normally 
occupies every third position since it is critical for correct formation of the Type I collagen 
molecule. 
 
In cat, the first described OI case was dated back to 1961 [160]. 30 years later, an OI-like 
syndrome was reported in a 12-year-old cat by radiographical and histological examinations 
and serum-based biochemical profile [158]. The third feline OI case reported in a 4.5-months-
old male domestic shorthair cat exhibited bilateral femoral fractures after falling from a low 
position [159]. Also, decreased radio-opacity and thin cortices of all long bones were identified 
[159]. Based on post mortem examinations the kitten was diagnosed with OI [159]. 
 
Few forms of canine OI have been clarified on a molecular level. A 12-weeks-old male Golden 




This dog carried a heterozygous missense mutation in COL1A1 (p.Gly208Ala), leading to an 
abnormal Gly-X-Y pattern of the collagen triple helix and resulting in over-hydroxylated alpha 
chains and delayed procollagen processing [161]. A heterozygous canine COL1A2 mutation 
due to replacement of "CTAG" at nucleotides 3991-3994 position with "TGTCATTGG" was 
reported leading to a C-terminal truncation in pro-alpha2(I) [162]. This genetic alteration 
resulted in increased density of pC-alpha2(I) and overhydroxylated alpha-chains [162]. The 
corresponding phenotype of the Beagle puppy presented with fractures was consistent with OI 
type III [162]. Furthermore, a missense mutation (p.L326P) in an evolutionary conserved 
domain of SERPINH1 was associated with a recessive form of OI in Dachshunds [97]. 
Therefore, in respects of clinical manifestations, etiology, and pathogenesis, canine and human 
OI appears to be similar [161]. 
2 Interdigital hyperplasia 
 2.1 Overview of lameness in dairy cattle 
Foot disorders and the resulting lameness represent promising and economically highly relevant 
research topics in dairy cattle health, due to high incidence rates, severity as well as rather long-
term duration processes [164-167]. The lesions that result in lameness in affected cattle cause 
severe pain and are a major issue in animal welfare. Lameness also has an economic impact, 
including losses from reduced milk productions, costs for culling, treatment costs, prolonged 
intervals of calving, as well as possibly nursing and caring labor [167]. It is expensive to rear 
replacement heifers and newly replaced cows are not initially as productive as mature ones 
[168]. A lame cow is less active in struggling for feed and therefore is more likely to be culled 
or die early. In addition, cows suffering from lameness before breeding show a decreased ability 
to conceive and cystic ovaries occur much more often in these animals [169, 170]. Lame cows 
are more reluctant to use an automatic milking system than healthy cows and when forced to 
do so, they show signs of stress [171]. 
 
From the perspectives of economic and animal welfare, foot diseases are an important health 
problem in dairy cows. Considerable funding is invested in the research relevant to bovine 
lameness. Numerous studies focused on risk factors and possible intervention strategies about 
foot disorders [172-175]. Some risk factors have been proved to be highly significantly 
associated with probabilities of lameness and foot lesions, including long-time standing on 
concrete, standing in wet slurry, factors which facilitating claw trauma, management failures 
especially in poor claw condition and inadequate foot caring [175]. Lameness control 
programmes on dairy farms have been developed and tested. However intervention remained 
widely ineffective, mainly due to inadequate implementation of programmes into practice. 
Primarily, the compliance in the program by the farmer and the veterinarian was insufficient 
[175]. Although lameness data are mainly collected by hoof trimmers, veterinarians and 
researchers should be familiar with this data information in order to play a key role in 
management of bovine lameness. More importantly, final action of dairy farmers are critical to 
improve dairy cow foot health. Therefore, awareness raising in farmers is most important. 
Farmers need to be trained to estimate foot health conditions and to realize correctly the 




the economic losses and consequences of foot disorders needs to be conveyed. Futhermore, 
databases detailing bovine lameness are expected to gain availability as management tools of 
foot disorders. 
 
There are various types of foot disorders distinguished. Interdigital phlegmon, also called 
interdigital necrobacillosis, footrot or foul-of-the-foot, is an acute or subacute necrotizing 
inflammation of the dermal layers of the interdigital skin and adjacent coronary band, causing 
sudden and severe lameness [176, 177]. The condition seems to be a mixed infection of multiple 
anaerobic pathogens with Fusobacterium necrophorum as the primary pathogen [176, 178]. 
Digital dermatitis, also called Mortellaro´s disease or foot warts, is a contagious disease of cattle 
characterized by ulcerative and necrotizing foot lesions [179, 180]. It is found worldwide as a 
leading reason of lameness in the cattle industry. Bovine interdigital dermatitis is an epi-
dermatitis of the interdigital skin extending to the dermis. This is likely caused by the infection 
with Bacteroides nodosus and Fusobacterium necrophorum [181]. If the infection is chronic, 
heel horn erosion becomes its consequence [181]. Sole hemorrhage, is a common noninfectious 
lesion in lame cows, characterized with blood stains in the sole of the claw. It is predominantly 
caused by physical or metabolic disturbances because of overloading and pressure on the claws. 
White line disease is mainly caused by physical damage. It occurs when the sole separates from 
the side wall of the claw which allows foreign matter to penetrate or infect this region, resulting 
in hemorrhages and lesions in the white line. Sole ulcer, also called Pododermatitis 
circumscripta, can be applied to all the ulcerations in the sole, toe, and heel zones [182]. It is a 
very painful type of noninfectious claw lesion, arising when soft tissue inside the sole gets 
damaged and horn can not be formed normally. Also, thin sole, scissor claws, and many other 
foot disorders have been detected in dairy cows. The objective of the second research project 
was to elucidate the molecular cause of bovine interdigital hyperplasia (IH). 
2.2 Research progress on interdigital hyperplasia 
2.2.1 Clinical introduction 
Interdigital hyperplasia, often referred to as tyloma or fibroma, is a firm and fibrous mass that 
protrudes from the interdigital space of the bovine claw. It may arise in one or multiple feet of 
an animal [183]. The lesion can gradually enlarge and become easily injured. Subsequently the 
affected feet provoke severe lameness. Skin injuries at the lesion site that are not treated 
properly and early enough, trigger foot infections. This secondary pathology very commonly 
invades deeper tissues, especially synovial structures, tendons, ligaments as well as bones [184, 
185]. It was observed that wet conditions and accumulation of slurry also impaired the integrity 
of the external structure of the feet. Thereby, ulceration and local or deep foot infection 
frequently occur [183, 186]. 
 
Most intriguingly, it is noticed that in dairy cows, IH predominantly affects the hind feet. In 
contrast, beef cattle commonly display a IH localization at the fore feet [187]. Recently, IH was 
also confirmed in the right fore limb of an eight years old male buffalo after case history, clinical 
and histopathological examinations [188]. Furthermore, lameness in sheep and goat is also very 
common, and its causes include claw disorders like footrot, interdigital dermatitis, interdigital 




muscular dystrophy [189]. In sheep and goat, lameness is one of the most important welfare 
issues and affects the industry and production, like decreased fertility, reduced growth rates of 
lambs and increased neonatal losses [189]. 
2.2.2 Prevalence and incidence 
Claw disorders are common in dairy cattle with a rather high prevalence. Frequently, more than 
70 % of the cows have one or more claw lesions or abnormal shapes in front or hind claws 
[190-193]. Prevalences of different distinguished claw disorders vary widely from each other. 
Interdigital dermatitis, acute laminitis, heel-horn erosion and sole hemorrhage are often 
identified with the highest prevalence rates [190, 192-194]. 
 
In 1992 the prevalence of IH was reported to be 8.8 % in dairy cows housed all year round in 
free stalls in the Netherlands [193]. 22 % of the affected animals displayed IH on both claws 
[193]. Also on Dutch dairy farms, its prevalence in different housing systems was identified to 
differ from 9 % (pasture period) to 14.2 % (housing period) [195]. More recent Dutch IH studies 
observed lower prevalence rates (5% - 5.9%) [190, 192]. Possible reasons for this could be that 
their research subjects were collected from different large-scale farms with varying breeds, age 
ranges and farm environmental factors [183, 193, 196-200]. 
 
The prevalence rate of IH is relatively high in association with some particular breeds, such as 
Hereford in UK and Holstein in Germany [197, 201]. Most cases of IH arise at the age of 1-2 
years. The frequency declines at around 6 years. So far no animals have been identified with a 
first appearance of IH at an age of 9 years or older [198, 199, 201]. Besides, the incidence of 
IH is commonly greater in males than in females [201]. 
2.2.3 Etiology and pathogenesis 
IH has been defined as the proliferative formation of firm tissue mass in the interdigital region 
because of dermatogenous reactions following persistent irritation and inflammation of the 
interdigital skin [202, 203]. The etiology of IH is multifactorial. Infectious processes seem to 
be implicated in the pathogenesis of IH. IH affected tissues exhibit decreased microbial richness 
and diversity of the outer skin bacterial flora compared to healthy skin [204]. A tendency of an 
increased presence of Porphyromonas spp. and Treponema spp. is observed in IH samples 
[204]. Also, other microorganisms seem to be implicated in the etiopathogenesis of serial 
lesions related to IH, including Dichelobacter nodosus, Fusobacterium necrophorum and 
Spirochetes [203]. Cattle with IH also often exhibit common lesions of infectious etiology, like 
digital dermatitis and interdigital phlegmon [183, 194, 203-205]. 
 
Despite being a prevalent lesion, the etiopathogenesis of IH is not fully elucidated. The 
following factors have been speculated to predispose the development of IH. A chronic 
environmental irritation provoked by poor hygiene, grazing stubble or rocky pastures, as well 
as the long-term irritation caused by inadequate hoof trimming can lead to a predisposition to 
IH [183, 200, 206]. Another perspective are endogenous factors. These include: overweight-
dependent excessive splaying of the toes, horn overgrowth causing manure trapped in the 




Underdeveloped interdigital ligaments, weak connective tissue, insufficient mineralization of 
the bone tissues causing irritation of the periosteum, as well as excess interdigital fat have been 
reported as additional predisposing factors [200, 207]. 
 
Histologically, IH lesion represents epidermal thickening of the interdigital skin [203]. It 
involves multiplex papilliferous epidermal ridges bridged and covered by large quantity of 
keratin [203]. IH is characterized by the thickening of varous epidermal layers, i.e. Stratum 
granulosum, spinosum and corneum [183, 203]. The skin from IH lesions is hyperkeratotic or 
parakeratotic [183]. There is also evidence of chronic inflammation in the lesions [183]. 
Furthermore, histopathological examination in the male buffalo with IH identified proliferating 
spindle-shape fibroblasts with streaming and interlacing bundles [188]. These bundles were 
running in criss-cross directions leading to the occasional formation of whorls [188]. 
2.2.4 Genetic background 
Holstein cattle are at higher risk of developing claw diseases than several other breeds, e.g. 
Meuse Rhine Yssel, Ayrshire and Norwegian cattle [208-210]. The breed differences indicate 
a potential genetic background for claw disorders. 
Heritabilities, repeatabilities and genetic correlations 
Heritabilities of feet disorders are generally low [190, 192, 211-215]. Studies in Holstein dairy 
farms in Eastern Germany identified the highest estimated heritabilities for IH (h2 = 0.115) in 
comparison to other common types of foot disorders, like digital dermatitis, sole ulceration and 
wall disorder [196]. In French HF dairy farms similar heritabilities of 0.14 were observed. 
Higher heritability of 0.43 was identified in trimmed cows [216]. However, heritabilities 
showed a tendency to decline when a larger number of cows were trimmed [216]. Heritability 
for IH was also found to be higher in younger animals with affection of more than one foot 
[200]. There seems to be a predisposition in some bull lineages [200, 206, 217]. 
 
The highest repeatability (0.33) was reported for IH compared to other claw disorders. This 
means that once a cow is affected with IH, it tends to be affected at subsequent occasions [216]. 
 
In 1964 IH has been reported to be significantly correlated with blood group factors [206]. A 
moderately strong genetic correlation between IH and dermatitis-erosion ((inter-)digital 
dermatitis and heel horn erosion) was identified (0.66 ± 0.08) [216]. The report indicated a 
possible similar genetic background for both diseases [216]. A negative genetic correlation was 
identified between IH and sole hemorrhage indicating a different genetic background [216]. 
Genetic correlations between trimming status and claw diseases were generally moderate to 
high in Holstein dairy (0.34 ± 0.07 with IH) [216]. 
GWAS reports 
Locomotion, lameness as well as feet and leg conformation are useful indicator traits for claw 
health. Routinely, they are recorded in most breeding schemes. The indicator traits including 
rear leg rear view, rear leg side view, hock quality, bone structure, foot angle and locomotion 




studies have detected several QTLs for these indicator traits in different dairy cattle breeds, like 
US Holstein cattle, Dutch Holstein cattle, German Holstein cattle, Danish Holstein Cattle, as 
well as in 3 French dairy cattle breeds (French Holstein, Normande, and Montbeliarde), 
although there was little coincidence among the QTLs reported [220-225]. 
 
Until 2015 in HF cattle significant (p < 0.05) and suggestive (p < 0.20) SNPs were identified 
for feet/claw disorders and trimming status [226]. The 10 significant SNPs, mainly located on 
BTA8, were associated with sole ulcer [226]. For IH, 17 suggestive associations were detected, 
located on chromosomes BTA6, BTA7, BTA8, BTA9, BTA11, BTA14, BTA20, BTA24, and 
BTA26 [226]. Interestingly among these, the SNP on BTA14 ARS-BFGL-NGS-4929 (64.0 
Mbp) co-localized with markers associated with foot angle, BMS1899- BM4513 (0–76 cM) 
[220, 226]. The SNP on BTA6 BTA-77057-no-rs (87.4 Mbp) associated with IH was close to 
marker FBN14 (88 cM) associated with foot angle [223, 226]. However, so far no 
genes/markers/variants with major effects on claw disorders or IH have been reported. 
Genetic parameters comparison in different parities, lactation and frequency 
Calving and the onset of lactation were reported to increase the susceptibility to feet disorders 
[227, 228]. In HF cattle, van der Spek et al. found that the frequency of interdigital hyperplasia 
(from 5.7% to 11.1%) and white line separation increased dramatically (from 10.8% to 20.5%) 
from the first to later parities [229]. Harder et al. identified a higher heritability in the first parity 
in comparison of first and later parities together for a combined claw and leg disorder trait in 
German Holstein dairy cattle [214]. Conversely, in Dutch dairy cattle, van der Linde et al. found 
that heritabilities of parity 1 and parities ≥2 were quite comparable for the majority of claw 
traits [190]. However, the largest differences in heritabilities (parities ≥2 minus parity 1) were 
identified for IH (+0.06), interdigital dermatitis (+0.03), and sole ulcer (+0.04) [190]. The report 
also showed that the genetic correlation between 1 and ≥2 parities for digital dermatitis, sole 
ulcer and IH were significantly different from unity [190]. Repeatabilities of parity 1 and 
parities ≥2 were generally low for most claw traits, but IH showed the highest estimates (0.42 
in first parity and 0.62 in later parities) [190]. Also, van der Spek et al. found that in HF cattle, 
IH had an increase in heritability from first parity to later parities [229]. But they reported that 
the genetic correlation between first and later parities was not significantly different from one 
for IH, double sole, sole ulcer, white line separation, and trimming status [229]. 
 
Van der Spek et al. showed that frequencies of feet disorders in HF cattle were generally similar 
from early to late lactation [229]. But a large difference in frequencies was found for trimming 
status, which was geneticaly correlated to IH [216, 229]. Gernand et al. found that genetic 
correlations for same claw disorders between different DIMs (days in milk) were high for 
adjacent test days in Holstein cows in Thuringia, but substantially dropped close to zero for 
distant test days [230]. They also reported that heritabilities for the same claw disorders were 
relatively stable during the course of lactation (DIM 50 - DIM 300), but tended to increase at 
early and late lactation [230]. Van der Spek et al. identified the largest absolute difference of 
heritabilities from early to late lactation for IH (from 0.07 to 0.09), white line separation (from 




correlation between early and late lactation did not significantly differ from one for double sole, 
IH, sole hemorrhage and sole ulcer [229]. 
It was argued that the heritabilities for disease resistance were higher under some specific 
environmental conditions in which animals could express resistance to disease [231]. In high-
frequency herds, cows are also more likely to express resistance against claw diseases. It has 
been reported that for bovine tuberculosis susceptibility genetic correlations between 
environments that differed in herd prevalence of the disease were all different from one [232]. 
For most claw traits, heritabilities were similar in herds with low and high frequencies of claw 
diseases [229]. However, IH and sole ulcer showed a lower heritability in low-frequency group 
(both 0.04) in comparison to high-frequency group (0.14 and 0.08, respectively) [229]. For sole 
ulcer a genetic correlation of (0.75±0.14) between low-frequency group and high-frequency 
group was found significantly different from one [229]. But for IH and many other claw traits, 
the genetic correlations between low-frequency group and high-frequency group did not 
significantly differ from one [229]. 
3 Ribosomopathy 
3.1 Ribosome biogenesis 
Ribosome biogenesis is the process of forming ribosomes which occurs in all cells. Ribosomes 
are complex macromolecular machines that serve as the site of biological protein synthesis 
either linked to endoplasmic reticulum or in cytosol. The eukaryotic ribosome contains a small 
40S (SSU) and large 60S (LSU) subunit. Ribosome biogenesis starts with the transcription of 
47S precursor rRNA by RNA polymerase I, and 5S rRNA by RNA polymerase III. The 47S 
rRNA precursor is afterwards modified, processed and cleaved into 18S, 28S, and 5.8S rRNAs. 
The 18S rRNA(1874 nt) together with 33 small subunit r-proteins forms the SSU. The 5S rRNA 
(120 nt), 28S rRNA (4718 nt), and 5.8S rRNA (160 nt) along with 47 large subunit r-proteins 
comprise the LSU. The SSU contains mRNA entry and exit sites, the path along which mRNA 
progresses for decoding of the genetic instructions. The LSU takes responsibility for peptide 
bond formation and contains a polypeptide exit tunnel. Both subunits are assembled into the 
translationally active mature 80S ribosome for protein synthesis. The assembly process requires 
the coordinated synthesis of 4 rRNA, 80 core r-proteins, more than 150 associated proteins as 
well as approximately 70 snoRNAs [233, 234]. The complex ribosome biogenesis is one of the 
most energy-consuming processes in eukaryotic cells. There are approximately 10 million 
ribosomes in a rapidly growing mammalian cell. An active HeLa cell synthesizes about 7500 
ribosomal subunits per minute [235]. Ribosome biogenesis is integral to all cell growth, 
proliferation and differentiation due to the roles of ribosomes in regulating the quality and 
quantity of proteins in a cell [236]. Perturbation of any step of ribosome biogenesis process can 
consequently lead to disorders in embryonic development or adult homeostasis. 
3.2 Research progress on ribosomopathies 
Ribosomopathies compose a collection of diseases, caused by mutations in the genes of 
ribosome biogenesis factors leading to an impaired or a decreased rate of ribosome 




but not in cattle. A summary of reported causative mutations of ribosomopathies, existing 
animal models and corresponding clinical defects are presented in Table 1. 
Diamond-Blackfan anemia (DBA) is a congenital erythroid dysplasia characterized by anemia 
caused by selective decrease or absence of erythroid precursors, macrocytosis and 
reticulocytopenia [237]. The estimated incidence is around 5 cases per million live births. The 
majority of patients can be diagnosed in the first year of life, with lethargy and pallor as the 
most common symptoms. Other possible clinical characteristics include craniofacial defects, 
thumb abnormalities, cardiac defects, and short stature [237, 238]. In 1999, RPS19 was first 
identified as a DBA gene, and mutations in it accounted for approximately one-forth of DBA 
cases [239, 240]. Over the past decades, a substantial progress has been made for improved 
explanation of the genetic causes of DBA. Changes in a large number of r-proteins in both SSU 
and LSU have been identified in DBA patients or families, including RPS17, RPS24, RPL5, 
RPL11, RPL35A, RPS7, RPS15, RPS27A, RPL36, RPS8, RPS14, RPL15, RPL18, RPS28, 
RPS26 and its binding partner TSR2 [241-248]. However, not all DBA cases can be attributed 
to r-protein dysfunction. A study has reported mutations in the hematopoietic transcription 
factor GATA1 [249]. Numerous animal models of DBA have been developed. Rpl11 
homozygous deletion in adult mice leads to lethality within a few weeks [250]. Rpl11 
heterozygous deletion in adult mice leads to anemia related with reduced erythroid progenitors 
and damaged erythroid maturation [250]. Rpl11-deficient zebrafish embryos shows 
hematopoietic failure [251]. Zebrafish models of RPS27 and RPL27 mutations show impaired 
erythrocyte production and damaged tail and/or brain development [252]. The findings in 
zebrafish and mouse DBA models were consistent with the genetic reports in humans and the 
models were also used for further mechanism studies. 
 
5q-syndrome, first described in 1974 as a refractory anemia with a distinct karyotype, shares 
clinical and pathologic features with DBA [253]. It is an independent subtype of 
myelodysplastic syndrome (MDS) and a de novo deletion of the region between bands q21 and 
q32 on chromosome 5 is its sole cytogenetic abnormality [254]. Clinically, 5q-syndrome 
presents mainly among females and a relatively low risk of progression to acute myeloid 
leukemia compared with other types of MDS. Blood findings include a severe macrocytic 
anemia, normal/elevated quantities of platelets with hypolobulated micromegakaryocytes and 
few blasts in both peripheral blood and bone marrow [255]. RPS14 was determined as a 5q-
syndrome gene in the RNA interference screen of each gene within the 5q-deletion region [256]. 
The haploinsufficient expression of RPS14 has been confirmed in patients with 5q-syndrome 
[256, 257]. RPS14 deficiency damages the processing of the 18S rRNA and the SSU formation 
[256]. A mouse model for human 5q-syndrome has been deleloped. With haploinsufficiency of 
the Cd74-Nid67 region including RPS14, it recapitulates the main features of the disease 
including macrocytic anemia, prominent dyserythropoiesis and monolobulated megakaryocytes 






































-lethality within a few weeks 
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SBDS -exocrine pancreatic insufficiency 
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TCOF1 -craniofacial malformation 
-microtia 
-malar and mandibular hypoplasia 
-developmental brain abnormalities 
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-decreased erythroblasts  
-reduced hematopoietic stem cell populations 
Roberts syndrome 
(RBS) [280, 281] 
ESCO2 -growth retardation 
-bilateral symmetric limb reduction 
-craniofacial defects 
 












EMG1 -growth retardation 
-macrocephaly 
-psychomotor delay 
-knee and hip contractures 
-abnormal feet 




Shwachman-diamond syndrome (SDS) is clinically characterized by exocrine pancreatic 
insufficiency, hematologic abnormalities, an increased risk of leukemia transformation as well 




1 in 50,000 births. Approximately 90% of SDS patients carry biallelic mutations in SBDS gene 
[262]. Mouse models have suggested the roles of SBDS in both hematopoietic and stromal cells 
of the bone marrow and ribosomal subunit maturation [263, 264]. 
 
Treacher-Collins syndrome (TCS) is a congenital disorder characterized by craniofacial 
malformation, microtia, malar and mandibular hypoplasia. Patients with TCS may present 
abnormalities of swallowing, airway, hearing and brain development [265, 266]. TCS occurs 
with an estimated frequency of 1 in 50,000 live births, primarily due to mutations in TCOF1 
gene [267]. The nucleolar phosphoprotein Treacle, encoded by TCOF1, colocalizes with 
upstream binding factor and RNA polymerase I. It plays an essential role in both rDNA 
transcription and rRNA methylation [268]. Mice haploinsufficient of TCOF1 show severe 
cranioskeletal defects, because the deficiency of the ribosome biogenesis regulator Treacle 
disrupts neural crest cell formation and proliferation [269]. Consistently, fish with TCOF1 loss-
of-function also displays craniofacial malformation [270]. However, unlike other 
ribosomopathies, TCS was not associated with hematologic abnormalities, suggested a different 
ribosomal based pathophysiology. 
 
Cartilage-hair hypoplasia (CHH) most commonly occurs in Old Order Amish and Finnish 
populations. It is clinically characterized by short stature resulting from skeletal dysplasia, 
hypoplastic hair, immunodeficiency, and increased risk of malignancies, particularly non-
Hodgkin lymphoma and basal cell carcinoma [271-273]. Additionally, the hematologic 
abnormalities may include macrocytic anemia and lymphopenia. CHH is an autosomal 
recessive disorder arising from mutations in the untranslated RMRP gene. RMRP encodes the 
RNA component of the RNase mitochondrial RNA-processing (MRP) complex. RNase MRP 
RNA is classified as a snoRNA and is mainly located in the nucleolus. snoRNAs assemble 
small nucleolar ribonucleoprotein complexes (snoRNPs) and play roles in various steps in the 
rRNA synthesis [274]. The viable homozygous RMRP null mice is not available, indicating that 
RMRP is indispensable for early embryonic development [275].  
 
Dyskeratosis congenita (DC) is an inherited bone marrow failure disease. It is clinically 
characterized by nail dystrophy, mucosal leukoplakia and reticular skin pigmentation [278]. In 
addition, patients often show somatic abnormalities and increased risk of immune deficiency, 
pulmonary complications and malignancy [278]. The syndrome is genetically heterogeneous. 
In addition to the most common X-linked form, autosomal dominant and recessive forms occur. 
In the past decades, around 50% DC patients have been assigned to mutations in the following 
genes, i.e. TERC, TERT, NOP10, NHP2, TINF2, TCAB1 [276-278]. This reveals that DC is a 
disorder caused mainly by defects in telomere maintenance. Since all the reported causative 
mutations are in genes whose products function in telomerase assembly or activity or in 
telomere integrity [278]. Studies on TERT-deficient mice establish a direct link between the 
loss of TERT activity, telomere shortening and damaged erythropoiesis [279]. 
 
Mutations in ESCO2, UTP4 and EMG1 have been detected in patients with Roberts syndrome 
(RBS), North American Indian Childhood Cirrhosis (NAIC) and Bowen-Conradi syndrome 
(BCS), respectively [280, 282, 284]. Their relevant functions in ribosome biogenesis have also 
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198. Böttger T. Incidence of interdigital overgrowth in black and white bulls and its 
relationship to age. Dtsch tierarztl Wschr. 1962;69:596. 
199. Comberg G, Meyer H, Weferling KG. Untersuchungen zur erblichkeit und pathogenese 
des zwischenklauenwulstes beim rind. 1. Mitteilung. Vergleichende untersuchungen über 
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Musculoskeletal anomalies generally in combination with severe clinical symptoms, comprise 
a heterogeneous group of fairly common and mostly fatal disorders in man and animals. In 
Holstein cattle, complex vertebral malformation and Brachyspina are the most important lethal 
osteodysplasias. Here we describe the molecular analysis of a case of osteogenesis imperfecta 
in an embryo transfer Holstein calf from clinically healthy parents. Causes of human 
osteogenesis imperfecta have been clearly explored with a number of candidate genes reported. 
In a comparative sequence analysis of the affected calf and healthy control cattle none of these 
hitherto known genes harbored any causative variants. Therefore, to identify associated 
genomic regions, a genome-wide association study was performed. A total of six significantly 
associated SNP loci above a Bonferroni threshold of -log10P= 5.7 (p = 0.05) were detected on 
bovine chromosomes 1, 5, 6, 17, 18, and 24. As the association analysis did not give an 
unequivocal evidence on the genetic cause, a whole genome re-sequencing of the affected calf 
and its parents was conducted. From this analysis 16 candidate genes with potential functional 
variants were selected. To determine the frequency of the variants and to analyze whether they 
were unique for the defect, 2,612 randomly chosen healthy Holstein cattle were genotyped. The 
analysis suggests that the defect was most likely due to a detrimental additive oligogenic effect. 
 
Introduction 
Development and maintenance of the skeletal system requires complex processes, which are 
characterized by continuous modelling and re-modelling providing structural and reservoir 
functions for the body throughout life. Hence, it seems comprehensible that a variety of 
pathological conditions interfere with a physiological development of the skeleton including 
genetic defects, nutritional deficiencies and hormonal disorders. This prompted a group of 
researchers in the early 1970s to establish a nosology and classification of human skeletal 
disorders in order to facilitate definitive diagnosis and help to delineate variant or newly 
recognized conditions [1]. Currently, this system includes 436 genetic disorders of the skeleton 
classified in 42 groups involving 364 genes [2]. Osteogenesis imperfecta (OI) together with 
other decreased bone density disorders form group 25 in this classification [2]. 
Osteogenesis imperfecta, also known as brittle bone disease, affects about 1/10,000 – 1/20,000 
live births in humans [3, 4]. OI patients exhibit prominent skeletal abnormalities causing bone 
fragility and deformity, with widely varying clinical severity. In addition, joint laxity, scoliosis, 
kyphosis, dentinogenesis imperfecta as well as craniofacial abnormalities may represent 
concomitant phenomena in OI patients. Prominent extra-skeletal accessory manifestations of 
OI comprise blue/gray sclerae, hearing impairment, lung abnormalities and hypercalciuria [3, 
5-7]. 
In humans, more than 90% of OI cases are caused by autosomal dominant mutations in the 
genes encoding type I collagen (COL1A1, collagen type I alpha 1 chain; COL1A2, collagen 
type I alpha 2 chain) [5]. A minority of OI cases occur as a result of recessive mutations in 
various genes, leading to different functional defects from structural to enzymatic as well as 
from intracellular transport to chaperones [3]. Most of these genes are involved in collagen 
metabolism, e.g. BMP1 (bone morphogenetic protein 1), CRTAP (cartilage associated protein), 
PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2), FKBP65 (65-kDa FK506-
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binding protein), HSP47 (heat shock protein 47), IFITM5 (interferon induced transmembrane 
protein 5), TRIC-B (trimeric intracellular cation channel subtype B), WNT1 (Wnt family 
member 1) and SP7/OSX (SP7 transcription factor/osterix) [8-16]. Depending on the causative 
gene and mutation, 13 different types of autosomal recessive and dominant OI are currently 
described in humans that are classified into five different groups based on their phenotypes 
[17]. 
Cases of OI in Holstein (HF) cattle have been reported since 1983 [18]. However, no causative 
mutations have been identified to date [18, 19]. A study with focus on non-collagenous proteins 
in OI affected Texan HF cattle showed a severe depletion of osteonectin and bone proteoglycan 
in bones and phosphophoryn in teeth [20]. OI has also been described in other cattle breeds 
(Charolais), sheep, cats and dogs [21-25]. However, only two forms of canine OI have been 
elucidated on a molecular level so far [26-29] and only recently COL1A1 de novo mutations 
have been described in Fleckvieh and Red Angus [30, 31]. 
 
Material and Methods 
Ethical Statement 
Blood samples were collected during routine diagnostic parentage control with written owner 
consent. Blood samples were drawn exclusively by local veterinarians. The collection of 
samples was approved by the Lower Saxony State Office for Consumer Protection and Food 
Safety (33.19-42502-05-17A196) according to §8a Abs. 1 Nr. 2 of the German Animal 
Protection Law. 
 
Tissue preparation and histology 
Tissues were fixed in 10 % formalin. Thin bone sections were prepared with a diamond band 
saw and decalcified in EDTA at 37 °C for up to 14 days, rinsed in tap water over night and 
routinely embedded in paraffin. Sections of 4 µm thickness were dewaxed in xylene, rehydrated 
in a decreasing ethanol series and H&E stained in an autostainer (Microm, HMS 740). 
 
DNA isolation and Sanger sequencing 
DNA isolation from blood and liver tissue (OI calf) samples was performed using MagNa Pure 
LC DNA Isolation Kit I (Roche Diagnostics, Germany) or a modified salting out procedure 
[32]. 
Using NCBI/Primer-BLAST, PCR primer pairs were designed (Table S1) [33]. A total volume 
of 25 μl was prepared for each PCR reaction, including 1× PCR reaction buffer plus 20 mM 
MgCl2, 0.5 μl of 10 mM dNTPs, 1 U FastStart Taq Polymerase (Roche), 1 μl of 10 pmol/μl 
each primer (Sigma-Aldrich, Germany), and 1μl of 20 ng/μl DNA. Reaction conditions 
included 95 °C for 10 min, then 30 cycles of 95 °C for 30 s, primer-specific annealing 
temperatures (Table S1) for 30 s and 72 °C for 45 s, followed by final elongation at 72 °C for 
7 min. 
Purification of PCR products was performed using Rapid PCR Cleanup Enzyme Set (New 
England Biolabs GmbH, Germany). Amplicons were sequenced using the BigDyeTM 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Thermo Fisher Scientific GmbH, 
Germany) and fragments were separated on an ABI PRISM 3130xl Genetic Analyzer (Life 
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Technologies, USA) following the manufacturers´ protocols. DNA sequences were aligned 
using SeqMan Pro software (DNASTAR Lasergene). 
 
Genome-wide association analysis (GWAS) 
For GWAS a total of 970 unaffected randomly chosen HF cattle (= controls) and the OI calf (= 
case) were genotyped using the Illumina BovineSNP50 BeadChip (56,919 SNP). Chips were 
processed on a HiScan SQ System (Illumina, USA) and raw data were converted using 
GenomeStudio 2.0.4 Software. Final reports were imported into SNP & Variation Suite 8.8.3 
(GoldenHelix, USA). Prior to GWAS data were filtered using a call rate <0.81, number of 
alleles >2, minor allele frequency (MAF) <0.05, and Fisher´s HWE <0.001 (based on controls) 
as marker dropping criteria. The low call rate of <0.81 had to be used due to the results of the 
OI calf. Heterozygosity rates were calculated for each individual based on autosomes and 
outliers were removed. Finally, LD pruning was applied using a window size of 100bp, window 
increment of 5 bp, r2 = 0.5 (LD threshold) and CHM (LD method). After filtering, 24,714 
markers and 926 samples (925 controls, 1 case) remained for further analysis and association 
was calculated using an additive model and the Cochran-Armitage trend as described [34]. 
Family based association was analyzed using PBAT [35]. Associations were regarded as 
statistically significant above a Bonferroni threshold of -log10P = 5.7 (p = 0.05). Associations 
of markers (-log10P-value, y-axis) were plotted against their chromosomal positions 
(UMD3.1.1, x-axis). 
 
Next generation sequencing and data analysis 
Paired-end sequencing was performed using the TG NextSeq 500/550 High Output Kit v2 
(Illumina) on a NextSeq500 platform. Sequence arithmetics (average depth of coverage, per 
base coverage) were calculated using bedtools [36, 37]. For the OI calf, its mother and father 
an average coverage of 36.3x, 27.2x and 38.3x was obtained, respectively. Sequences were 
aligned to the latest bovine genome build ARS-UCD1.2 using BWA-MEM with alignment 
parameters t = 8, A = 1, B = 4, O = 6, E = 1 and k = 31. For variant calling sorted bam-files 
were converted to vcf using samtools and bcftools [38]. Vcfs were imported into SNP & 
Variation Suite 8.8.3 (GoldenHelix, USA) for calling of SNPs and indels. Sequences were 
aligned to 3,093 samples of Run 7 of the 1000 bulls genome project [39]. SVDetect and delly 
was used for identification of larger genomic structural variations [40, 41]. CANDID v1.1 was 
used for gene prioritization [42, 43]. 
 
Genotyping of variants 
Unless otherwise specified all positions refer to bovine genome assembly ARS-UCD1.2. 
Genotyping of ABCA13 variants, i.e. rs381405831 (4:g.7398705T>C) and rs110593220 
(4:g.7324346T>C) was realized by multiplex-fluorescence resonance energy transfer (FRET)-
PCR [44]. ABCA13_rs381405831 primers and ABCA13_rs110593220 primers (Table S1) 
were designed using NCBI/Primer-BLAST [33]. Probe/anchor, rs381405831_6-FAM/ROX 
and rs110593220_6-FAM/Cyanine 5 (Table S1), were designed using MeltCalc [45, 46]. 
Multiplex PCR was performed on LightCycler 480 (Roche) in a total volume of 15μl using 
FastStart Taq DNA Polymerase, dNTPack (Roche). One reaction mix included 0.75 U Faststart 
Taq DNA Polymerase, 3 nmol dNTPs, 6 pmol of each primer and probe, 1x Q-solution (Qiagen, 
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Hilden, Germany), 1x PCR reaction buffer plus 20 mM MgCl2, and 20 ng of DNA. Cycling 
conditions were 95°C for 10 min, followed by 35 cycles of 95°C for 30 s, 61°C for 30 s and 
72°C for 30 s. The final elongation step was 72°C for 7 min. Melting analysis was performed 
using the appropriate filter set (483-610 filter comb for rs381405831; 483-670 filter comb for 
rs110593220) and the following program: 95°C for 30 s, 37°C for 30 s, 95°C continuous 
acquisition mode (2 acqui./°C), ramp rate 0.14°C/s, followed by 37°C for 10 s. 
Amplification refractory mutation system (ARMS) [47] was designed to genotype QRFPR 
variant rs209556962 (6:g.4198178C>T). Primers, rs209556962_WTfwd/rev and 
rs209556962_MUTfwd/rev (Table S1), were designed using NCBI/Primer-BLAST [33], to 
amplify the wild type or mutant specific fragment with an internal amplification control 
sequence in a single reaction. The ARMS-PCR was performed on LightCycler 480 (Roche) in 
a total volume of 25 μl. One reaction mix included 1 U Faststart Taq DNA Polymerase (Roche), 
5 nmol dNTPs (Roche), 10 pmol of each primer, 1x PCR reaction buffer plus 20 mM MgCl2 
(Roche), 1x EvaGreen (Jena Bioscience, Germany) and 10 ng of DNA. Cycling conditions were 
95°C for 10 min, followed by 28 cycles of 95°C for 30 s, 66°C for 30 s and 72°C for 25 s. Final 
elongation step was 72°C for 7 min. Melting analysis was performed using the appropriate filter 
set and the following program: 95°C for 1 min, 40°C for 1 min, 75°C for 1 s, 90°C continuous 
acquisition mode (25 acqui./°C), ramp rate 0.02°C/s. 
PCR-restriction fragment length polymorphism (PCR-RFLP) was used to genotype IFITM5 
rs209568970 (11:g.82966108C>A). The IFITM5_RFLP primers (Table S1) were designed 
using NCBI/Primer-BLAST [33]. Cycling conditions were 95°C for 10 min, followed by 36 
cycles of 95°C for 30 s, 61°C for 30 s and 72°C for 15 s. Final elongation step was 72°C for 7 
min. Total volume of 25 μl RFLP master mix was prepared with 10 μl PCR product, 20 U BanII 
(NEB), 1x CutSmart Buffer (NEB) and 1x EvaGreen (Jena Bioscience, Germany). On 
LightCycler 480 (Roche), digestion mixture was incubated at 37°C for 4 h. Melting analysis 
was performed using the appropriate filter set and the following program: 70°C for 1 s, 95°C 
continuous acquisition mode (5 acqui./°C), ramp rate 0.11°C/s, followed by 37°C for 1 s. 
 
Statistical analysis 
Hardy-Weinberg equilibrium was calculated as described [48]. 𝜒2 scores were converted to p-
values using R [49]. 
 
Data availability 
The data that support the findings of this study are available from the corresponding author 
upon reasonable request. Supplemental tables (Table S1-S4) have been uploaded to figshare. 
 
Results 
Clinical and histological analysis 
The affected OI calf was produced by embryo transfer and delivered four weeks prematurely. 
There were no reports of a previous transmission or case of osteogenesis imperfecta for both 
parents in their ancestry which excluded a dominant trait. As several sires in the pedigree have 
been widely used in Holstein breeding a recessive inheritance was also unlikely, however was 
not excluded completely. As shown in Figure 1 the pedigree reflects a normal Holstein cattle 
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family structure with no unexpected increased relatedness among animals due to inbreeding 
[50]. It is evident that sires Ro and especially Be appear more often in the paternal as well as 
maternal ancestral line. 
Due to sucking weakness, bronchopneumonia and hypogammaglobulinemia, the OI calf was 
hospitalized shortly after birth. Four days after birth the OI calf developed a comminuted 
fracture of the right tibia distal of the knee joint and two days later a similar fracture on the left 
side without any obvious traumatic influence. The OI calf had to be euthanized and was 
dissected for diagnosis. Post mortem examination revealed comminuted fractures of both tibias 
approximately 2-5 mm distal of the epiphyseal plate (Figure 2). Fractures were accompanied 
by hemorrhages in the adjacent tissue. Additional fractures and disruptions of the articular 
cavities of the scapulae were determined. Other organs were without special findings. Bone 
tissue showed marked osteopenia characterized by thin cortical bone and thin trabeculae of the 
spongiosa, often consisting of woven instead of lamellar bone. Only few osteoclasts were 
present throughout the sections. Multifocally, trabeculae were widely separated by abundant 
mucinous matter, replacing bone marrow cells. In some regions, a direct transition between 
columnar cartilage and fibrous connective tissue was observed (Figure 3 A-D). From the 
postmortal and histological examinations an osteogenesis imperfecta (OI) was diagnosed. 
 
Analysis of known candidate genes causative for osteogenesis imperfecta 
In a first attempt a comparative sequencing of all potential OI candidate genes reported in 
humans, i.e. COL1A1, COL1A2, IFITM5, SERPINF1, CRTAP, LEPRE1, PPIB, SERPINH1, 
FKBP10, SP7, BMP1, TMEM38B and WNT1, was performed in a cohort comprising the 
affected OI calf, its parents and randomly chosen DNA of healthy Holstein cattle as controls. 
Only within IFITM5 and CRTAP non-synonymous variants were detected (Table 1). 
In IFITM5 a homozygous missense variant (NC_037338.1:g.82966108C>A) was identified in 
the OI calf resulting in an amino acid exchange ENSBTAP00000041562.3:p.Ala30Ser. This 
variant was heterozygous in the parents and would therefore correspond to a recessive 
inheritance of the disorder. However, the homozygous alternative genotype was also detected 
in a healthy control excluding this variant as single causative candidate. Moreover, this variant 
seems to be tolerated as predicted by SIFT (0.42) [51]. 
In CRTAP a heterozygous inframe 9bp-deletion (NC_037349.1:g.7459319_7459327del) 
resulting in a truncation of three amino acids (ENSBTAP00000028588.4:p.Val18_Ala20del) 
was identified in the OI calf reflecting a dominant defect if causative for the disorder. The 
deletion was inherited by the mother and was also detected in one healthy control excluding 
this variant as causative. 
The analysis of hitherto known candidate genes associated with human OI unexpectedly did 
not result in the identification of any single causative mutation in the OI calf. Therefore, a 
genome-wide association analysis was performed. 
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Table 1. Detection of DNA variants in osteogenesis imperfecta candidate genes 
Gene Position Variant Genotypes (OI-family)  Controls 
   OI calf Mya) Sb)  Ref/Ref Ref/Alt Alt/Alt 
IFITM5 11:g.82966108 rs209568970 Alt/Alt Ref/Alt Ref/Alt  1 4 1 
CRTAP 22:g.7459319 rs466604499 Ref/Altc) Ref/Alt Ref/Ref  1 1 0 
a) My: Mother (see also Fig. 1); b) S: Father (see also Fig. 1); c) Ref: Reference allele, 








Fig. 1 Pedigree of the affected calf 
The pedigree depicts the six generations family structure of the affected calf. Selected 
individuals are indicated with letters. The pedigree was generated using the java webstart 
application Pedigree Chart Designer v2.0 (PCD). 
  




Figure 2 Post mortal examination of left hint limb 
The picture shows the medial view of the left hint limb including the proximal part of the 
metatarsus, ankle and distal part of the tibia. A comminuted fracture of the distal tibia is 
accompanied by hemorrhages in the adjacent tissue.  




Fig. 3 Histological analysis of bone of the affected calf 
Tissue sections (4 µm) were prepared and hematoxylin/eosin stained as described in Materials 
and Methods. (A-D) Affected calf showing (A) mucinous matter (Mc) replacing bone marrow 
(Bm), (B) direct transition of columnar proliferative cartilage (cpCh) to fibrous connective 
tissue, (C) not clearly separated metaphyseal bone (Mpb) from the hypertrophic chondrocytes 
(hCh) and (D) woven instead of lamellar bone. (E, F) Age-matched control calf with trabecular 
structured bone (Tbn) and distinct zones of epiphyseal growth. 
 
Genome-wide association analysis 
The OI calf was compared with 925 control cattle including parents and seven ancestors. 
Different genetic models were applied (dominant, recessive, basic allelic, genotypic, additive), 
however only the additive model resulted in associations above a genome-wide Bonferroni 
significance level (-log10P = 5.7, p = 0.05). As shown in Figure 4 single SNPs with significant 
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associations were detected on bovine chromosome 1 (ARS-BFGL-NGS-93288, -log10P = 5.88), 
5 (BTA-00226457, -log10P = 6.48), 6 (HapMap49852-BTA-107572, -log10P = 7.33), 17 (BTB-
01327818, -log10P = 5.77), 18 (ARS-BFGL-NGS-64158, -log10P = 8.57) and 24 (BTB-
01542431, -log10P = 5.85). Besides OI candidate genes SP7 and WNT1 which are located on 
BTA5 upstream the respective associated SNP (BTA-00226457), none of the other associated 
SNPs were located in an OI candidate gene harboring chromosomal region. To analyze whether 
the associated chromosomal regions contained any potential so far unknown candidate genes, 
regions of 500kb up- and downstream of the associated SNPs were investigated. All genes in 
the corresponding regions were analyzed in silico regarding their function in bone, skeletal or 
cartilage development. According to the available databases (OMIM, MGI, OMIA, PubMed) 
none of the genes located in these regions have been described to be involved in any of the 
above traits. These results finally prompted us to perform a whole genome re-sequencing of the 
OI calf and its parents. 
 
Fig. 4 Manhattan plot of genome-wide association analysis for osteogenesis imperfecta 
Marker associations are plotted as negative log-transformed P values against the position in the 
bovine genome (UMD3.1.1). Eight markers exceed the genome-wide significance threshold of 
-log10P = 5.7 (black line). 
 
Next generation sequencing of OI calf and parents 
5´-, 3´-UTRs, splice sites and coding regions of the OI calf were analyzed for the presence of 
recessive homozygous polymorphisms, de novo mutations, compound heterozygous 
polymorphisms and larger genomic structural variations [52]. No structural variations, de novo 
mutations or compound heterozygous polymorphisms were identified qualifying as candidates. 
A total of 10,995,619 recessive homozygous variants were identified in the OI calf. 374 
functional variants (1 deletion, 347 nonsynonymous variants, 4 nonsense mutations, 22 splice 
sites or promoter variants) remained after filtering. To further narrow potential OI causative 
variants, gene prioritization was performed using osteogenesis, bone fracture, loose joint, brittle 
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teeth, white sclera and bone deformity as keywords. This resulted in a list of 1,038 prioritized 
genes. The two candidate gene lists were compared and sixteen genes were present in both lists, 
i.e. QRFPR, ABCA13, MMAB, CCDC137, PAG21, KRT20, SOX8, GTPBP4, FAT4, SPOCK2, 
CACNA1I, COL6A6, AGER, MXRA5, CRTAC1 and CALCR. Validation of all detected 
functional variants was performed in these 16 genes, including 2 stop gain variants, 2 start lost 
mutations, 2 splice sites variants, 16 missense mutations, 1 inframe deletion and 1 frameshift 
insertion. Furthermore, in 8 functionally unknown genes 7 stop gain variants and 1 frameshift 
insertion were analyzed. All variants were comparatively sequenced in the affected calf, its 
parents and healthy control cattle (Table S2). None of the filtered and selected variants proved 
to be the only causative mutation. 
 
Discussion 
The molecular mechanisms underlying OI in humans have been analyzed in detail with a 
number of candidate genes reported. Although cases of OI have been reported in Charolais and 
Holstein cattle already decades ago, only recently different causative COL1A1 de novo 
mutations have been described in Fleckvieh and Red Angus [18, 30, 31, 53]. In other domestic 
species, i.e. sheep, cat and dog, cases of OI have also been published, however, only in dogs 
causative mutations in COL1A1, COL1A2 and SERPINH1 have been elucidated [21, 22, 26, 27, 
29]. Similar to humans, where OI is classified as orphan disease, OI also seems to be a rare 
disorder with low prevalence in domestic animals as estimated from the number of specific 
cases reported so far [54]. Hence, it was a fortunate coincidence that such a rare case of an OI 
calf had been reported to us and liver tissue was made available for further molecular analysis. 
In an initial attempt to identify causative mutations, all known OI associated genes that have 
been identified in humans were comparatively sequenced between the affected calf and its 
parents. Surprisingly, only two functional variants in IFITM5 and CRTAP were identified. The 
inframe 9bp-deletion in CRTAP, however, had to be excluded as candidate, as it was 
heterozygous in the OI calf and transmitted by the healthy mother, also heterozygous for this 
variant. An additional proof for the exclusion of this variant came from the identification of an 
unrelated heterozygous healthy control cattle. Although the remaining variant in IFITM5 was 
homozygous in the OI calf corresponding to a recessive inheritance, it was also rather unlikely 
to be the only cause as the same homozygous genotype was detected in a healthy control cattle. 
From the direct comparative sequencing of known OI candidate genes it was evident that the 
defect of the calf must have been the result of other and/or additional mutations in so far 
unassociated genes. To determine which further loci and genes could be involved, a GWAS 
was performed. For the GWAS it was possible to include seven relatives of the OI calf in the 
analysis also allowing a family-based association test using PBAT [35]. The results indicated 
that the defect was of oligogenic origin with at least six genome-wide significantly associated 
chromosomal regions. Furthermore, it was evident that the defect was presumably due to an 
additive genetic effect. However, a search in the flanking chromosomal regions up- and 
downstream of the associated SNPs did not lead to any apparent potential causative genes. 
Hence, a whole-genome re-sequencing of the OI calf and its parents was conducted and 
sequences examined regarding functional and structural variants. In combination with a gene 
prioritization it was finally possible to obtain a short list of 16 functional relevant candidate 
genes and eight additional loci with loss of function due to nonsense or frameshift mutations 
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(Table S2). All variants were genotyped in the OI family and unrelated healthy control cattle. 
Variants in AGER, SOX8, PAG21 and two loci (ENSBTAG000000313, NSBTAG000000303) 
were excluded because the OI calf was either homozygous wild type or heterozygous. For the 
remaining variants, the OI calf carried the homozygous mutated genotype, however, this 
genotype was also detected in several healthy control cattle. These results again supported the 
previous findings that the defect was most likely of oligogenic origin. Although, most of the OI 
cases in humans and domestic animals reported so far are caused by distinct monogenic 
mutations, an oligogenic additive genetic effect was not a complete surprise as combined 
heterozygous mutations in human OI have recently been described [55]. 
Therefore, different combinations of the remaining variants were tested in respect to their 
occurrence in the cattle population (2,612 random samples). Finally, the variants in ABCA13 
(rs381405831, rs110593220), QRFPR (rs209556962) and IFITM5 (rs209568970) together 
were uniquely present in the OI calf (Table 2). ABCA13 is a member of the ATP-binding 
cassette subfamily A and has a basic function as transmembrane transporter [56]. ABCA13 is 
highly expressed in bone marrow stromal cells which can differentiate into bone, cartilage, 
adipocytes and hematopoietic supporting tissue [57]. A highly significant deviation from HWE 
of the homozygous carriers of the alternative allele (rs110593220) was detected for within the 
2,612 samples with 𝜒2 = 252.97 (p = 1.2e-55). For QRFPR a direct involvement in bone 
formation has already been demonstrated and QRFPR-/- mice show thin osteochondral growth 
plates, thickened trabecular branches and reduced osteoclast numbers. As the stop gain variant 
in QRFPR had been included on the bovine BeadChip (DEU_QRFPR4152699_4152699, 
DEU_QRFPR4152699_4152699_r) it was possible to determine the frequency of the genotypes 
in a larger cohort of 139,364 cattle showing a significant under-representation of the affected 
homozygous genotype (𝜒2 = 9.7, p = 0.008). It is therefore conceivable that variants in both 
genes together with IFITM5 could contribute to the development of OI. 
 
Table 2. Iterative determination of genotype frequency of OI causative variants in 2,612 
random samples of Holstein cattlea) 
Gene Position Variant Ref>Alt Ref_Ref Ref_Alt Alt_Alt 
ABCA13 4:g7398705 rs381405831 T>C 1479 978 155 
ABCA13 4:g7324346 rs110593220 T>C 1104 1442 66 
QRFPR 6:g4198178 rs209556962 C>T 19 28 16 
IFITM5 11:g82966108 rs209568970 C>A 6 10 0 
a) ABCA13 genotypes were determined in 2,612 samples. Samples harboring the homozygous 
alternative alleles were genotyped for the stop gain variant in QRFPR. The remaining 16 









In conclusion, the analysis of the OI case revealed an oligogenic origin of the disease 
attributable to additive effects of three candidate genes, i.e. ABCA13, QRFPR, and IFTIM5. All 
three genes are directly or indirectly involved in bone development and formation or have been 
described as causative for human OI previously. The elucidation of an additive genetic effect 
demonstrates the complexity of the disease. The pathogenesis of the OI case presented here 
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Table S1 Primers for genotyping of functional variants 
Primer name 5´- 3´ Ta (°C)a) Product size (bp) 
IFITM5_exon1 primers  61 276 
IFITM5_Ex1fwd CTCGAAGCAGGAGTCCGAG   
IFITM5_Ex1rev CATGAAATGCTCCTGGGCC   
CRTAP_exon1 primers  60 564 
CRTAP_Ex1.1fwd TCTAAAGGAGCGATCAGCGG   
CRTAP_Ex1.1rev CCAAAGAGGCGCAACTCCG   
FKBP10_exon4 primers  60 560 
FKBP10_Ex4fwd GAGACAAGGAGCTGGTGGAT   
FKBP10_Ex4rev GGTGGAATGGAGGTCTCAGC   
RB1CC1_exon17 primers  60 305 
RB1CC1_Ex17fwd AAGTGGAGAGGAAGAGCGTG   
RB1CC1_Ex17rev TGCTTCACTGCGATACAGGG   
OGN_exon2 primers  60 422 
OGN_Ex2fwd GGAGAGTGGAAGGACTGTTCA   
OGN_Ex2rev ACGTGGAATGGCAAATGGTG   
MATN1_exon2 primers  60 583 
MATN1_Ex2fwd CTAAGTAGCCCCTGATGCCC   
MATN1_Ex2rev AGCCAGAGGGAGCAGCATTA   
QRFPR_rs209556962 primers  60 204 
rs209556962fwd GGCATGGAAATTCAGGGATTACG   
rs209556962rev TGCCTAAACCAGAATTCTCCGA   
QRFPR_rs208471741 primers  60 204 
rs208471741fwd GGCATGGAAATTCAGGGATTACG   
rs208471741rev TGCCTAAACCAGAATTCTCCGA   
CALCR_rs42358343 primers  56 236 
rs42358343fwd TCTACATCTGCCACCAGGAG   
rs42358343rev GATCTCCATAGCGACGACCTC   
CRTAC1_rs110294381 primers  56 141 
rs110294381fwd TGTGTTCCTCCCCTGCTACA   
rs110294381rev CCCGTCAATGATCCTCAGGT   
MXRA5_rs382394831 primers  60 228 
rs382394831fwd TCCACTTCCGGTCTTTGTAGG   
rs382394831rev AGGCGAAGGTGGAGAATGTG   
MXRA5_rs382875669 primers  60 602 
rs382875669fwd GATCCGGCATGGGAGATGAA   
rs382875669rev AGTTGCACCCACGGTCTTC   
MXRA5_rs209853968 primers  60 602 
rs209853968fwd GATCCGGCATGGGAGATGAA   
rs209853968rev AGTTGCACCCACGGTCTTC   
AGER_rs110735388 primers  61 208 
rs110735388fwd TCTCCCTCATCCTCCCTGTT   
rs110735388rev GAAGTGGAGAGACAGGAGCC   
COL6A6_rs110043748 primers  60 237 
rs110043748fwd TGATGTGATGCTTTGCACGC   
rs110043748rev GGAAGAGGGTGGCACATTCA   





 65 585 
rs135349128fwd AGAAGACAGAGGGCAGGGAA   
rs135349128rev CAGAGGTCAGGTCAGGCAGA   
SPOCK2_rs136889096 primers  65 389 
rs136889096fwd ATCCCTGTGCCCTCCTATCC   
rs136889096rev TAGTTACCGGCCTCCTCCAG   
FAT4_rs207788317 primers  61 155 
rs207788317fwd AGCCCCTTTCTCCAAGTCCT   
rs207788317rev TCTTGCTTCTCCTTCCCAGC   
FAT4_rs208893611 primers  61 152 
rs208893611fwd TGTCGTTGAGAATGCGCCTA   
rs208893611rev TCAACCTCCCAGACACAGGA   
GTPBP4_rs380469336 primers  64 229 
rs380469336fwd GGAAGAGGAAGCGGGAAGAC   
rs380469336rev CAGCACTCAGAAAAGCGCAC   
SOX8_rs438171974 primers  64 309 
rs438171974fwd CGGGAACAAAAAGCCGTTGA   
rs438171974rev GGTGTCCATGTTCCCGATGA   
KRT20_rs211283960 primers  61 308 
rs211283960fwd ACGGACTCTGCTCCATCCAT   
rs211283960rev AGCTTGCTAGGCGGTCATTT   
PAG21_rs137216482 primers  61 305 
rs137216482fwd TACACAACACGGATCTCCCG   
rs137216482rev TGACTGGATTTGTCCGAGGC   
CCDC137_rs110483301 
primers 
 61 173 
rs110483301fwd GCCTACAGGGCGCTAAAGAG   
rs110483301rev AAGGACGCTCAACTGTAGGC   
CCDC137_rs41577609 primers  61 173 
rs41577609fwd GCCTACAGGGCGCTAAAGAG   
rs41577609rev AAGGACGCTCAACTGTAGGC   
CCDC137_rs207551614 
primers 
 61 283 
rs207551614fwd CTTCCCGAGTCCAGTCAACC   
rs207551614rev TCACCGAACTTCACCGTGTC   
CCDC137_rs109405883 
primers 
 61 278 
rs109405883fwd TGCCTTCATCACTCTCCCCT   
rs109405883rev GCTCCCACTCACGCTTTCTT   
MMAB_rs110898391 primers  60 337 
rs110898391fwd AGGTTGAGAAATGCGGGAGG   
rs110898391rev TTCATAGAGCGCTCCAGCTTTTAG   
ABCA13_rs381405831 primers  61 124 
rs381405831fwd CTTTACAGATGCCACCGAGG   
rs381405831rev GCGTGCATCTAGGAGTGAGA   
rs381405831_6-FAM™/ ROX™    
ABCA13rs831_probe ggaaactggaggaagaCcatagt-6-FAM™   






ABCA13_rs110593220 primers  61 117 
rs110593220fwd ACAGGAAGTGTGTGAGCCAG   
rs110593220rev CCATCCTCTCTGCGTCCATC   
rs110593220_6-FAM™/ 
Cyanine 5 
   
ABCA13rs220_anchor gctgcagcctcttggccccg-6-FAM™   
ABCA13rs220_probe Cyanine 5-accctgtccCgcaccac-Phosphate   
ENSBTAG00000048150_rs136
954177 primers 
 61 425 
rs136954177fwd TAGGGGCATTGGGCTAGGAT   
rs136954177rev TCAACCATGCAACCCCATCA   
ENSBTAG00000040140_rs382
569063 primers 
 66 240 
rs382569063fwd GGACGCTTGGATCACCTCAC   
rs382569063rev ACACTGACAGCTAATTGTAGCAT   
ENSBTAG00000047781_rs109
822444 primers 
 66 192 
rs109822444fwd ACGTCTTTGTTGTTCCACCCT   
rs109822444rev GTGATGGGTGACGGTTGGT   
ENSBTAG00000047145_rs134
136884 primers 
 59 396 
rs134136884fwd GAAGGGGGTCCTAAAGCTGG   
rs134136884rev ACTGGAATTCCTGAGGGGGT   
ENSBTAG00000000560_rs207
627937 primers 
 67 216 
rs207627937fwd CTACAACCACCCCATGCACA   
rs207627937rev TTGTGATTCCTGGCCTGTCG   
ENSBTAG00000040580_rs211
629862 primers 
 62 137 
rs211629862fwd AACCCTGTACTCCCCCTTCA   
rs211629862rev TCAGGGAGAAACAGACGCAC   
ENSBTAG00000031361_rs209
803099 primers 
 66 183 
rs209803099fwd ACAACACATTGAGCTCCCCT   
rs209803099rev TCCGAAGGATGGGGACAAGT   
ENSBTAG00000030386_rs468
298771 primers 
 57.8 322 
rs468298771fwd GGGATCACTGAGTCCTGGCT   
rs468298771rev CAATCAGGGAGAGTGGGACG   
IFITM5_RFLP primers  61 71 
rs209568970_RFLPfwd GCAACGCCCACACGG   
rs209568970_RFLPrev CACGGACCAGATCAAGTGG   




rs209556962_WTrev GCTGTCACTCTGCTGTGTCT   
rs209556962_MUTfwd GGCATGGAAATTCAGGGATTACG 66 177 






GTPBP4_SDM-RFLP primers  60 91 
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Table S2 NGS variant analysis 
Position a) Gene Effect rs number 
Genotypes of OI trio Genotypes of healthy control cattle 
O calf Father Mother Total No. Ref_Ref Ref_Alt Alt_Alt 
AC_000163.1:g.4152699C>T QRFPR stop gained rs209556962 ALT_ALT REF_ALT REF_ALT 87 32 38 17 
AC_000163.1:g.4152598G>A QRFPR Missense rs208471741 ALT_ALT REF_ALT REF_ALT    2 
AC_000161.1:g.10615176T>C CALCR Missense rs42358343 ALT_ALT REF_ALT REF_ALT 3 1 1 1 
AC_000183.1:g.18900025C>T CRTAC1 Missense rs110294381 ALT_ALT REF_ALT REF_ALT 3  2 1 
AC_000187.1:g.138882706G>A MXRA5 Missense rs382394831 ALT_ALT REF_ALT REF_ALT 9 7 1 1 
AC_000187.1:g.138885931_138885933del MXRA5 Inframe rs382875669 ALT_ALT REF_ALT REF_ALT 9 7 1 1 
AC_000187.1:g.138886370G>C MXRA5 Missense rs209853968 ALT_ALT REF_ALT REF_ALT 9 7 1 1 
AC_000180.1:g.27009084T>C AGER Start lost rs110735388 REF_ALT REF_ALT REF_ALT 9 8 1 0 
AC_000158.1:g.153331589A>G COL6A6 Missense rs110043748 ALT_ALT REF_ALT REF_ALT 3   3 
AC_000162.1:g.111601472_111601475dup CACNA1I Frameshift rs135349128 ALT_ALT REF_ALT REF_ALT 3   3 
AC_000185.1:g.28314738T>C SPOCK2 Missense rs136889096 ALT_ALT REF_ALT REF_ALT 9 5 3 1 
AC_000174.1:g.32713454C>A FAT4 Missense rs207788317 ALT_ALT REF_ALT REF_ALT 21 16 3 2 
AC_000174.1:g.32887994C>T FAT4 Missense rs208893611 ALT_ALT REF_ALT REF_ALT 21 16 4 1 
AC_000170.1:g.46690834G>A GTPBP4 Missense rs380469336 ALT_ALT REF_ALT REF_ALT 196 141 54 1 
AC_000182.1:g.790262A>C SOX8 Missense rs438171974 REF_REF REF_ALT REF_ALT 6 6 0 0 
AC_000186.1:g.39052073A>T PAG21 stop gained rs137216482 REF_REF REF_ALT REF_ALT 7 3 4 0 
AC_000176.1:g.51758959A>G CCDC137 Missense rs110483301 ALT_ALT REF_ALT REF_ALT 7 4 0 3 
AC_000176.1:g.51759001G>A CCDC137 Missense rs41577609 ALT_ALT REF_ALT REF_ALT 7 4 0 3 
AC_000176.1:g.51759668T>C CCDC137 Missense rs207551614 ALT_ALT REF_ALT REF_ALT 7 4 0 3 
AC_000176.1:g.51761251C>T CCDC137 Missense rs109405883 ALT_ALT REF_ALT REF_ALT 7 1 3 3 
AC_000161.1:g.7309608T>C ABCA13 splice donor rs381405831 ALT_ALT REF_ALT REF_ALT 28 19 7 2 
AC_000161.1:g.7237183T>C ABCA13 Missense rs110593220 ALT_ALT REF_ALT REF_ALT 62   2 
AC_000176.1:g.41731744C>T KRT20 start lost rs211283960 ALT_ALT REF_ALT REF_ALT 7 2 3 2 
AC_000174.1:g.65887778A>C MMAB splice acceptor rs110898391 ALT_ALT REF_ALT REF_ALT 7 0 4 3 
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AC_000158.1:g.119962272G>A ENSBTAG00000048150 stop gained rs136954177 ALT_ALT REF_ALT REF_ALT 5 1 2 2 
AC_000186.1:g.38843505dup ENSBTAG00000040140 frameshift rs382569063 ALT_ALT REF_ALT REF_ALT 7 0 5 2 
AC_000182.1:g.39309083G>T ENSBTAG00000047781 stop gained rs109822444 ALT_ALT REF_ALT REF_ALT 7 4 0 3 
AC_000186.1:g.38405455G>C ENSBTAG00000047145 stop gained rs134136884 ALT_ALT REF_ALT REF_ALT 7 5 0 2 
AC_000176.1:g.13526380C>T ENSBTAG00000000560 stop gained rs207627937 ALT_ALT REF_ALT REF_ALT 30 21 8 1 
AC_000178.1:g.20157841C>A ENSBTAG00000040580 stop gained rs211629862 ALT_ALT REF_ALT REF_ALT 6 2 2 2 
AC_000170.1:g.63327326C>T ENSBTAG00000031361 stop gained rs209803099 REF_ALT REF_ALT REF_ALT 7 1 6 0 
AC_000160.1:g.103500366G>T ENSBTAG00000030386 stop gained rs468298771 REF_REF REF_ALT  6 6 0 0 
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Interdigital hyperplasia in Holstein cattle is associated with a missense mutation in the signal peptide 




Bovine interdigital hyperplasia (IH) is a typical disease of the foot with varying prevalence 
depending on age, breed and environmental factors resulting in different degrees of lameness. 
In studies based on assessments of claw health status at time of hoof trimming and applying 
genetic-statistical models to analyze this data, IH consistently exhibits high estimates of 
heritability in the range of 0.30 to 0.40. Although some studies have identified chromosomal 
regions that could possibly harbor causative genes, a clear identification of molecular causes 
for IH is lacking so far. While analyzing the large database of claw health status as documented 
at time of hoof trimming, we identified one herd with extreme prevalence of IH of > 50 % of 
affected Holstein dairy cows. This herd subsequently was chosen as the object of a detailed 
study. A total of n = 91 cows was assessed and revealed a prevalence of 59.3 % and 38.5 % for 
IH cases, documented as ‘at least one-sided’ or ‘two-sided’, respectively. Cows were genotyped 
using the BovineSNP50 BeadChip. A genome wide association study revealed two significantly 
associated chromosomal positions (-log10P = 5.57) on bovine chromosome 8 (BTA8) located 
in intron 5 and downstream of the receptor tyrosine kinase-like orphan receptor 2 (ROR2) gene. 
As ROR2 plays a key role in ossification of the distal limbs and is associated with 
brachydactylies in humans, it was a reasonable candidate for IH. A comparative sequencing of 
the ROR2 gene between cases and controls revealed two missense variants in exon 1 
(NC_037335.1:g.85,905,534T>A, ARS-UCD1.2) and exon 9 
(NC_037335.1:g.86,140,379A>G, ARS-UCD1.2), respectively. Genotyping of both variants in 
the cohort of 91 cattle showed that the exon 1 variant (rs377953295) remained significantly 
associated with IH (p < 0.0001) as a risk factor of the disease. This variant resulted in an amino 
acid exchange (ENSBTAP00000053765.2:p.Trp9Arg) in the N-terminal region of the ROR2 
signal peptide which is necessary for proper topology of the polypeptide during translocation. 
Quantification of ROR2 mRNA and ROR2 protein showed that the variant resulted in a 
significant suppression of ROR2 expression in homozygous affected compared to wild type and 
carrier cows. 
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Foot diseases are a major and increasing health problem in dairy cattle and show rather high 
prevalence [1]. Often over 70% cows in dairy herds experience one or more front or hind claw 
lesions or deformities during their life [2-5]. Due to milk production losses and veterinary costs 
as well as culling of severe cases, feet and leg are of economical importance [6, 7]. Besides 
disorders like double sole, sole ulcer, sole hemorrhage, white line separation, and digital 
dermatitis, interdigital hyperplasia (IH) plays an important role with a prevalence of around 5-
14.2 % [2, 4, 5, 8]. Normally IH begins with a small and painless protrusion of the interdigital 
skin which sometimes can already be diagnosed at calf age. In the final stage clinical signs of 
IH are firm tumor like masses found in the interdigital space with skin lesions that can result in 
deep necrosis and phlegmonous inflammations. 
Infectious processes are possibly implicated in the pathogenesis of IH. Tissues affected with IH 
exhibit decreased microbial richness and diversity compared to healthy skin [9]. An increased 
susceptibility for IH has been described depending on the number of parities and lactations. 
From first parity to later parities, IH frequency and estimates of heritability increase [10]. In a 
longitudinal study in which cows that had been affected with IH were analyzed with respect to 
the point in time when they were first diagnosed with IH, it was found that about 50 % of all 
cows that were susceptible were affected in their first lactation, another 25 % in their second 
lactation and another 10 to 15 % in third lactation while the remaining cows only exhibited IH 
very late in life [11]. 
Already in very early literature, it has been hypothesized that a genetic predisposition is the 
main cause for the development of IH [12]. In more recent studies using data collected at time 
of hoof trimming, rather elevated estimates of heritabilities are found [1, 16, 17] and these even 
amount to magnitudes of 0.30 to 0.40 when threshold models are used or estimates from a linear 
estimation are converted to the underlying scale [13-16]. In a study estimating the odds ratio 
for cows to be affected by IH when comparing the status of female ancestors, it was found that 
the risk to be affected increases 8.5-fold when comparing cows with affected dams and grand-
dams vs. cows with non-affected ancestors [17]. Up to recently, evidence for a genetic 
predisposition on a molecular level has been scarce and inconclusive [1, 16, 18]. In a very recent 
study, a number of chromosomal regions putatively involved in the etiology of IH have been 
identified [19]. 
Aim of the present study was to identify genes that might play a role in the development of IH 
by means of a genome-wide association study based on a case-control design. As a further step, 
genes in the identified regions were subject to sequencing for detection of single nucleotide 
polymorphisms. Finally, polymorphic sites were further analyzed with respect to differences in 
gene expression. A herd of dairy cows exhibiting an extreme prevalence of IH served as a basis 
for the study. 
 
Materials and Methods 
Ethical statement 
Clinical inspections and sampling of cattle were done during routine hoof trimming on farm 
with written owner consent. Samples were taken exclusively by local veterinarians. The 
Interdigital hyperplasia in Holstein cattle is associated with a missense mutation in the signal peptide 
region of the tyrosine-protein kinase transmembrane receptor gene 
 
 75 
collection of samples was approved by the Lower Saxony State Office for Consumer Protection 
and Food Safety (33.19-42502-05-17A196) according to §8a Abs. 1 Nr. 2 of the German 
Animal Protection Law. 
 
Clinical investigations and sample collection 
Clinical investigations were completely connected to the hoof trimming routine as practiced on 
the study farm. The hoof trimming routine consisted on visits of the hoof trimmer at intervals 
of approximately three months. At each visit, around half of the cows of the herd were subject 
to hoof trimming, i.e. two consecutive visits were supposed to cover the entire herd. The herd 
therefore was inspected at two consecutive hoof trimming events in October, 2016, and January, 
2017. Another hoof trimming event in January 2018 was used to take 2mm fine needle biopsies 
(Tru-Punch Sterile Disposable Biopsy Punch, Sklar Instruments, VWR, Germany) from 
hyperplastic interdigital skin of eight affected cows for RNA and protein analysis. Healthy 
control samples were collected from an abbatoir. 
A total of 110 cattle was assessed at visits 1 (V1) and 2 (V2) (Table 1). Excluding animals that 
had been presented twice, i.e. at the first and second visit, n = 91 animals remained. During the 
visits, individuals were inspected visually, phenotypes were recorded and pictures were taken 
for documentation. Blood samples were taken for DNA extraction during visits 1 and 2 (n = 
91). 
 
Table 1 Results of clinical inspections during two farm visits 
Clin. inspectiona) Cattle (n =) Interdigital hyperplasia affected (n =) 
  Type A (%)b)  Type B (%)c) 
V1 58 34 (59)  22 (38) 
V2 52 37 (71)  26 (50) 
Total 110 71 (65)  48 (44) 
 
a) V1: First farm visit in October 2016, V2: Second farm visit in January 2017; b) IH type A: 
At least one affected hind leg; c) IH type B: Both hind legs affected. 
 
Genome-wide Association Study (GWAS) and statistical analysis 
Genotyping of the 91 samples was performed using the Illumina BovineSNP50 BeadChip. Raw 
data were processed using GenomeStudio V2011.1 (Illumina, San Diego, USA). Final reports 
were imported into SVS 8.8.3 (Golden Helix, Bozeman, USA) and low quality SNPs were 
filtered if call rates < 90 %, MAF < 0.01 and Fisher´s HWE p < 0.0001 (based on controls). LD 
pruning was performed using default parameters. Samples were filtered with call rates < 0.95. 
Mitochondrial DNA and sex chromosomes were excluded from the analysis. After filtering 70 
samples and 45,232 SNPs remained in the analysis. Genome-wide associations were calculated 
under an additive and dominant model [20]. Associations were regarded as genome-wide 
statistically significant above a threshold of -log10P = 5.47 (p = 0.05) [21]. Associations of 
markers (-log10P-value, y-axis) were plotted against their chromosomal positions (UMD3.1.1, 
x-axis). 
All n = 91 cows from V1 and V2 were genotyped for rs43572154 and rs377953295. Genotype 
counts, genotype and allele frequencies were calculated for both variants. Hardy-Weinberg test 
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was calculated according to Rodriguez et al. [22]. Frequency distribution for alleles and 
genotypes vs. types of definitions of disease status (Type A IH, Type B IH) was calculated 
using both Chi-squared test and Fisher’ s Exact Test. 
 
Sanger sequencing and genotyping 
DNA was extracted from blood samples using MagNa Pure LC DNA Isolation Kit I (Roche 
Diagnostics, Mannheim, Germany) or a modified salting out procedure [23]. For Sanger 
sequencing of ROR2, primers were designed to amplify exons and intron-exon boundaries 
(Supplementary Table S1) [24]. PCR products were purified with Rapid PCR Cleanup Enzyme 
Set (New England Biolabs GmbH, Frankfurt am Main, Germany) and sequenced using the 
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Fisher Scientific GmbH, 
Schwerte, Germany) on an ABI PRISM 3130xl Genetic Analyzer (Life Technologies, Foster 
City, USA) according to the manufacturers´ protocols. The same primers were used for 
sequencing PCR products. SeqMan Pro software (version 15.0.0 (160) Intel, DNASTAR) was 
used for sequence alignments. Genotyping of variants NC_037335.1:g.85,905,534T>A and 
NC_037335.1:g.86,140,379A>G (ARS-UCD1.2) was done by diagnostic sequencing. 
 
RNA and protein preparation 
Harvested tissue was immediately immersed in RNAlater (Ambion, ThermoFisher Scientific, 
Dreieich, Germany) and stored at 4°C. Tissue samples were homogenized in the Qiazol Lysis 
Reagent (Qiagen, Hilden, Germany). According to the user guide of TRIzol Reagent, total RNA 
was extracted and eluted in 30 μl RNase-free water and the concentration and purity were 
measured on a NanoDrop (ThermoFisher Scientific, Dreieich, Germany). 0.2 µg of RNA was 
converted to cDNA using Maxima H Minus First Strand cDNA Synthesis Kit with dsDNase 
(ThermoFisher Scientific, Dreieich, Germany). 
Protein was extracted and solubilized in an optimized EDTA lysis buffer [25]. Protein 
concentrations were measured using the Bradford assay [26]. RNA and protein samples were 
stored at –80° until further use. 
 
ROR2 isoform detection and semi-quantitative real time RT-PCR 
Potential ROR2 isoforms were analyzed in tissue samples of the interdigital region, lung and 
spleen of healthy cattle using primer pairs ROR2_cDNA_1/2_fwd (5´-
CAGCCCTGTTCCAACTCTGA-3´), ROR2_cDNA_1/2_rev (5´-
CCGTATTCCGTCTTGCGGAT-3´), ROR2_cDNA_2_fwd (5´-
GGCATGGAGTACCTGTCCAG-3´), and ROR2_cDNA_2_rev (5´-
GGCCAGGTCTTTGTGGACCA-3´). 
Real-time quantitative PCR was performed using cDNA synthesized from RNA isolated from 
fine needle biopsies (FNB) of IH affected cattle and controls. Statistical testing for mRNA 
expression normalized to GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and ß-actin 
was determined by the 2-𝛥𝛥CT method using Microsoft Excel for Mac 2011 [27]. GAPDH was 
amplified using primers GAPDH_cDNA_fwd (5´-CCACTCCCAACGTGTCTGTT-3´) and 
GAPDH_cDNA_rev (5´-GCTTCACCACCTTCTTGATCTCATC-3´) [28]. ß-actin was 
amplified using primers ACTB_cDNA_fwd (5´-GTCATCACCATCGGCAATGAG-3´) and 
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ACTB_cDNA_rev (5´-AATGCCGCAGGATTCCATG-3´) [29]. Relative ROR2 expression 
(𝛥CT) was analyzed in 10 tissue samples of a healthy Holstein cow using GAPDH as 
normalizer. 
 
Western blot analysis 
Protein samples (10 μl) were mixed with 4X Bolt LDS Sample Buffer (Novex, ThermoFisher 
Scientific, Dreieich, Germany) supplemented with 10% 2-mercaptoethanol, and incubated at 
70°C for 10 min. Electrophoresis was performed on 8% Bolt Bis-Tris Plus Gels (Novex, 
Thermo Fisher Scientific) in Bolt MES SDS Running Buffer (Novex, ThermoFisher Scientific, 
Dreieich, Germany) at 165 V for 57 mins. Proteins were transferred to nitrocellulose membrane 
(ThermoFisher Scientific, Dreieich, Germany) at 15 V for 1 h in transfer buffer. After blocking 
overnight at 4°C, immunoblots were incubated with primary anti-ROR2 antibody (1:500, 
ABIN2706970, Cohesion Biosciences, Aachen, Germany) and anti-β-actin (1:10,000, A5441, 
Sigma Aldrich, Darmstadt, Germany) at room temperature for 1 h. Incubation with the 
secondary antibodies (1:5000 for #1706515, 1:10,000 for #1706516, Bio-Rad, Munich, 
Germany) was done at room temperature for 1 h. Immunoblots were developed with Western 
ECL (GERPN2109, Sigma Aldrich, Darmstadt, Germany). Images from Western blots were 
captured and quantification was performed with ImageJ software [30]. 
 
Results 
Identification of an IH associated region on bovine chromosome 8 (BTA8) using a genome-
wide association study 
During V1 and V2 a total of 110 cattle was clinically inspected (Fig. 1) and blood samples 
drawn (Table 1). After removing duplicates an initial set of 91 samples remained. After quality 
filtering of genotyping data as described in Materials and Methods 70 cattle were used for the 
genome-wide association study. Depending on the type of IH 41 cases/29 controls (type A) or 
29 cases/41 controls (type B) were analyzed using an additive and/or dominant genetic model. 
For both IH types and genetic models markers on BTA8, i.e. ARS-BFGL-NGS-64395, ARS-
BFGL-NGS-69582, showed highest -log10P values above a chromosome-wide significance 
threshold of -log10P = 5.47 (p = 0.05) (Fig. 2A, B). ARS-BFGL-NGS-64395 is located in intron 
5 and ARS-BFGL-NGS-69582 downstream of the ROR2 gene (tyrosine-protein kinase 
transmembrane receptor) (Fig. 2B). Genes flanking ROR2, i.e. SPTLC1 (long-chain base 
subunit 1 of serine palmitoyltransferase), NFIL3 (interleukin 3-regulated nuclear factor) and 
AUH (3-methylglutaconyl-CoA hydratase) were excluded as potential candidates as they have 
been reported in humans or mice to be causative for hereditary sensory and autonomic 
neuropathy (type 1A), susceptibility to inflammatory bowel disease and 3-methylglutaconic 
aciduria (type 1), respectively [31-36]. On the other hand, as ROR2 had been associated with 
terminal limb malformations in humans including cutaneous syndactyly, it seemed to be a 
reasonable candidate for further analysis [37-44]. 
To identify IH associated variants, ROR2 was comparatively sequenced using 8 IH affected and 
8 healthy control cattle. DNA sequence comparison revealed two variants in the coding region 
of ROR2 in exon 1 (NC_037335.1g.85905534T>A; rs377953295; ARS-UCD1.2) and exon 9 
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(NC_037335.1g.86140379A>G; rs43572154; ARS-UCD1.2). The variant in exon 1 resulted in 
an amino acid exchange from tryptophan to arginin (ENSBTAP00000053765.2:p.Trp9Arg) 
located in the N-terminal signal peptide. The variant in exon 9 caused an amino acid exchange 
from methionine to valine (ENSBTAP00000053765.2:p.Met901Val) at the C-terminal 
intracellular end outside of any functional domain [45]. 
 
 
Fig. 1 Clinic signs of bovine interdigital hyperplasia 
During hoof trimming cattle were clinically inspected. From all affected animals pictures were 
taken for documentation. A)-D) show different developmental stages with increasing size of 
dermal hyperplasia found in the interdigital space with skin final skin lesions (D). D) 
Interdigital hyperplasia after hoof trimming. 
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Fig. 2 Manhattan plot of genome-wide association study for bovine interdigital 
hyperplasia 
A) Marker associations are plotted as negative log-transformed P values against the position in 
the bovine genome (UMD3.1.1). Two markers ARS-BFGL-NGS-64395 and ARS-BFGL-
NGS-69582 exceed the genome-wide significance threshold of -log10P = 5.47 (black line). 
B) Enlargement of the associated chromosomal region on BTA8 flanking markers ARS-BFGL-
NGS-64395 and ARS-BFGL-NGS-69582. Genes located within this region, i.e. SPTLC1, 
ROR2, NFIL3 and AUH, are shown with black bars at their approximate positions. 
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Genotyping and association analysis of ROR2 variants 
To determine the genotype frequencies of rs377953295 (exon 1) and rs43572154 (exon 9) in 
IH affected (IHA) and control cattle (IHF) both variants were genotyped in all clinically 
inspected cattle. Results are summarized in Table 2. Although for both SNPs the analyzed 
cohorts were in Hardy-Weinberg equilibrium, it was striking that the A_A-genotype 
(rs377953295) was not detected in healthy individuals. Fisher´s exact test using a 2x3 
contingency table showed that the genotype distribution for this SNP was significantly 
deviating from expectation (p = 4.9e-4) whereas the distribution of genotypes for rs43572154 
(exon 9) did not deviate. SNP rs43572154 (exon 9) was therefore excluded as potential 
causative variant. Association of rs377953295 (exon 1) was further investigated comparing the 
frequency distribution of the three genotypes with the different clinical IH types in a total of 94 
cattle. As shown in Table 3 the presence of the A_A-genotype significantly associated with the 
different clinical forms of IH. Differences between type A and B IH are detectable in the 
distribution of genotypes T_T and A_T. Furthermore, it is evident that heterozygous individuals 
are more often affected which suggests that the A-allele at rs377953295 (exon 1) seems to be 
associated with an increased risk to develop IH. 
In summary, the genome-wide association study identified a significantly associated 
chromosomal region on BTA8 harboring a potential candidate gene with a missense variant 
that is significantly overrepresented in IH affected cattle. As the variant rs377953295 (exon 1) 
results in an amino acid exchange at position nine of the ROR2 signal peptide it was 
hypothesized that this could influence expression and finally an insufficient translocation of 
ROR2 into the plasma membrane. 
 
Table 2 Genotype frequencies of ROR2 variants rs377953295 (exon 1) and rs43572154 
(exon 9) in type A affected and IH free (= healthy) cattle 
 rs377953295 (exon 1)  rs43572154 (exon 9) 
 T_T A_T A_A  A_A A_G G_G 
IHFa) 32 5 0  1 10 15 
IHAb) 23 23 7  3 17 34 
Total 55 28 7  4 27 49 
HWEc) (𝝌2) 1.53  0.01 
 
a) IHF: Interdigital hyperplasia free; b) IHA: Interdigital hyperplasia affected; c) HWE: Hardy-
Weinberg equilibrium of total cohort. 
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Table 3 Statistical evaluation of SNP rs377953295 (exon 1) as causative variant for type A 
and type B interdigital hyperplasia 
 Type A IHa)  Type B IHb) 
 T_T A_T A_A  T_T A_T A_A 
IHFc) 21 4 0  35 6 0 
IHAd) 38 24 7  24 22 7 
Total 59 28 7  59 28 7 
F-statistic 7.16  16.94 
P-values(𝝌2, FETe)) 0.0279, 0.0026  0.0002, < 0.0001 
 
a) In type A IH: IHF = no IH, IHA = at least one IH at one hind leg; b) In type B IH: IHF = no 
IH or only one IH, IHA = IH at both hind legs; c) IHF: Interdigital hyperplasia free; d) IHA: 
Interdigital hyperplasia affected; e) FET: Fisher´s exact test. 
 
Expression of ROR2 in the interdigital skin is significantly downregulated in affected 
homozygous animals harboring the A-allele at rs377953295 
ROR2 is a classical housekeeping gene harboring a GC-rich and TATA-less promoter [46]. 
Therefore, it was expected that ROR2 is widely expressed as shown in humans [47]. However, 
as ROR2 has also been shown to be mainly expressed in early and expression abates during 
later embryonal development, it was first of all important to demonstrate ROR2 expression in 
tissues of adult cattle [48, 49]. Therefore, 10 different tissues/organs, i.e. interdigital skin, lung, 
spleen, brain, heart, liver, stomach, intestine, urinary bladder and bone marrow, were collected 
at an abattoir and analyzed. As shown in Fig. 3A expression was detected at different levels in 
all analyzed samples. Importantly, ROR2 was expressed in the skin of the interdigital region 
further supporting the genomic data that it could be involved in the development of IH. In 
addition, it has been reported that two isoforms of ROR2 (ROR2-201, ROR2-202) exist 
differing in the usage of two alternative first exons. Only ROR2-201 harbors the exon with 
variant rs377953295 and therefore it was necessary to prove that this isoform was expressed in 
the interdigital skin. Using an isoform specific PCR it was possible to show that both isoforms 
are expressed in the interdigital skin (Fig. 3B). Finally, the association of the three genotypes 
of variant rs377953295 with the expression of ROR2 in the interdigital skin was tested. For this 
purpose samples of the hyperplastic interdigital skin of cattle harboring the T_T-, A_T- and 
A_A-genotypes at rs377953295 were compared using interdigital skin of healthy cattle as 
normalizer. As depicted in Fig. 4 the different genotypes within the IH affected samples showed 
significant reductions between genotype T_T vs A_A as well as A_T vs A_A. The difference 
between T_T vs A_T was not significant. The differences in ROR2 mRNA levels were also 
reflected in the ROR2 protein levels (Fig. 5). Note, that for the protein extraction of the T_T 
genotype only one hyperplastic skin sample was available and therefore a statistical verification 
was omitted. For reasons of animal welfare we refrained from additional sample collections. 
However, the ROR2 protein amount in the T_T sample was clearly above the other two 
genotypes. 
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In summary, the functional analyses are in agreement with the genomic data that a reduction of 
ROR2 expression on RNA and protein level seems to be associated with the risk to develop IH 
and is highest in cattle with the A_A genotype at rs377953295. 
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Fig. 3 Detection of ROR2 transcripts and isoforms in different bovine organs and tissues 
A) Organ and/or tissue samples (De = interdigital dermis, HE = heart, Br = brain, Li = liver, Int 
= intestine, Ur = urinary bladder, Bo = bone marrow, Lu = lung, Sp = spleen, St = stomach) 
were collected from healthy cattle at an abattoir and RNA extracted. ROR2 transcripts were 
amplified as described in Material and Methods. Relative expression levels were calculated 
using the average 𝚫Ct-values of three biological replicates with GAPDH as normalizer. 
B) ROR2 isoform specific primers (see Materials and Methods) were used to amplify RNA 
from IntD = interdigital dermis, Lu = lung and Sp = spleen (NTC = non template control). Two 
amplicons corresponding to isoform ROR2-202 and isoforms ROR2-201/202 together can be 
seen. Amplicons were separated on a 2% agarose gel and visualized using Ethidium bromide 
staining. 
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Fig. 4 Comparison of ROR2 expression in hyperplastic interdigital skin tissue 
Interdigital skin tissues were collected from 3 A_A, 3 A_T, 2 T_T cattle during clinical 
inspection at the farm using fine needle biopsies. Genotypes A_A, A_T and T_T correspond to 
the missense variant in exon 1 (rs377953295). Two samples were taken from healthy control 
cattle at an abattoir as reference. RNA was extracted and expression of ROR2 and internal 
control was done by real-time quantitative PCR using primers listed in Materials and Methods. 
Calculation of ROR2 expression fold change in the IH affected cattle was done using the 2-𝚫𝚫Ct 
method with ß-actin as normalizer and the average expression of ROR2 in the healthy controls 
as reference [50]. ROR2 expression fold change of the three genotypes is shown as box-and-
whisker plot. Significance was calculated using a one-tailed t-test with p < 0.05. 
  
Interdigital hyperplasia in Holstein cattle is associated with a missense mutation in the signal peptide 




Fig. 5 Quantification of ROR2 protein in hyperplastic interdigital skin tissue 
Interdigital skin tissues were collected from 3 A_A, 3 A_T, 1 T_T cattle during clinical 
inspection at the farm using fine needle biopsies (see also Fig. 4). Genotypes A_A, A_T and 
T_T correspond to the missense variant in exon 1 (rs377953295). Two samples were taken from 
healthy control cattle at an abattoir as reference. Protein extracts were separated on 8% Bolt 
Bis-Tris Plus gels and transferred to nitrocellulose membranes. Membranes were incubated 
with primary anti-ROR2 antibody and anti-β-actin. Blots were developed with Western ECL. 
Images were captured and intensity quantification was performed with ImageJ software [30]. 
Significance was calculated using a one-tailed t-test with p < 0.05. As only one samples for 
genotype T_T were available statistical significance is not depicted. 
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Interdigital hyperplasia is a serious health issue in cattle production. Besides the clinical and 
animal welfare relevance it also has tremendous effects on the general performance of the 
animal. Therefore, it is of great importance to elucidate the molecular genetics of IH and find 
potential causative variants that could be used for selection in future breeding programs. 
In the study described here a herd with a high prevalence of IH was identified which was 
followed over a longer period of time allowing a repeated thorough clinical inspection and 
sampling during professional hoof trimming. A GWAS was performed showing two genome-
wide significantly associated SNP loci at around 87.5Mb on BTA8. In a previous study, 17 
suggestive associations (p < 0.20) spreading across the bovine genome had been detected for 
IH in Holstein cattle [51]. Although five of them were also located on BTA8 (8Mb, 24Mb, 
25MB, 43Mb), the IH associated region in this study was located further downstream. 
Fortunately, only four genes were located in the direct chromosomal proximity of the associated 
SNPs. Three of the genes, i.e. SPTLC1, NFIL3 and AUH, were excluded from further analysis 
because they had been reported to be causative for other disorders with rather different 
detrimental phenotypes in humans and mice [31-36]. On the other hand, the remaining gene, 
i.e. ROR2, seemed to be the most promising positional candidate due to the fact that one of the 
associated SNPs was directly located within the gene (intron 5). A DNA sequence comparison 
of ROR2 in IH affected and healthy cattle revealed two missense variants in exon 1 and exon 
9, respectively. However, only the variant in exon 1 (rs377953295) resulting in an amino acid 
exchange in the signal peptide of ROR2 (ENSBTAP00000053765.2:p.Trp9Arg) remained 
significantly associated with IH after screening the cohort of cattle at the farm. So far ROR2 
variants have not been associated with any other disorder or trait in cattle and therefore the 
identification of the missense variant was a novel finding. 
But also regarding its biological function, ROR2 was obviously an interesting candidate. ROR2 
(Receptor Tyrosine Kinase-like Orphan Receptor 2) belongs to the receptor tyrosine kinases 
(RTK), a large superfamily of transmembrane glycoproteins. Previous studies have shown that 
ROR2 is important for the formation of the distal limbs [52, 53]. Molecular genetic analyses in 
humans have revealed that mutations in ROR2 cause dominant Brachydactyly type B and 
recessive Robinow Syndrome, with terminal limb malformations as common symptoms [37-
44, 54]. Defects of the distal limbs have also been observed in ROR2-/- mice, mainly due to 
abnormal cartilage and growth plate development as well as ossification [53, 55]. Hence, the 
reported functional role, determined positional association and identification of a missense 
variant in ROR2 in IH affected cattle were convincing enough to extend the analyses. 
Therefore, ROR2 expression was analyzed in the interdigital skin. Although earlier studies 
indicated that ROR2 expression in adults was restricted to parathyroid, testis and uterus, it is 
now known that its expression may be more widespread than originally thought [47, 56]. During 
embryogenesis ROR2 expression was identified in heart, lungs, face and limbs [52]. Our data 
show that different amounts of ROR2 mRNA can be detected in interdigital skin, lung, spleen, 
brain, heart, liver, stomach, intestine, urinary bladder and bone marrow of adult cattle. In 
addition, two ROR2 isoforms (ROR2-201, ROR2-202) were detected differing in the usage of 
an alternative first exon. Especially isoform ROR2-201 harboring the exon with the missense 
variant was detectable in the interdigital skin. Although compared to other organs and/or tissues 
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expression of ROR2 in the interdigital skin was intermediate, the identification of ROR2 
transcripts was important to support its assumed role in IH development. Furthermore, the 
relative amount of ROR2 transcripts significantly differed between the three genotypes in 
correlation with the IH status. Homozygous A_A IH affected cattle showed significantly 
reduced ROR2 expression in the hyperplastic interdigital skin which is also reflected in the 
amount of ROR2 protein. In addition, ROR2 expression in hyperplastic compared to normal 
interdigital skin showed a significant reduction which explains the observation that hyperplastic 
skin alterations were also present in T_T or A_T cattle. The down-regulation of ROR2 could 
be explained by a general mechanism of transcriptional quality control. For instance, when 
mutant signal sequences fail to bind to the signal recognition particle at the ribosome exit site, 
the nascent chain instead contacts Argonaute2 and the mutant mRNAs are specifically degraded 
[57]. Specific mRNA degradation preemptively regulates aberrant protein production [57]. 
However, other mechanisms resulting in the general down-regulation of ROR2 in hyperplastic 
interdigital skin have to be taken into account [58, 59]. 
In the etiology of IH, the role of ROR2 in signal transduction seems to be important. The main 
histological alterations in hyperplastic interdigital skin are proliferating fibroblasts, multiplex 
papilliferous epidermal ridges as well as increased cellularity in the stratum granulosum and 
stratum spinosum [60, 61]. In this respect, it is important to note that Wnt signaling pathways 
play crucial roles in the regulation of skin development and epidermal stem cells behavior [62, 
63]. Sustained epidermal activation of Wnt/β-catenin signaling not only stimulates fibroblast 
proliferation, but also causes structural remodeling of the entire dermis [64]. Binding of Wnt 
isoforms to Fz-LRP complex (frizzled-low density lipoprotein receptor-related protein) 
generates β-catenin signaling, whereas binding to the atypical receptor tyrosine kinase ROR2 
can inhibit this activity [65]. The significant down-regulation of ROR2 could affect the 
inhibition of the canonical Wnt pathway, resulting in the abnormal cellular processes related to 
aberrant epidermal development. This potential biochemical effect is consistent with our 
finding that ROR2 seems to be an IH suppressor and that decreased expression level of ROR2 
leads to IH development. Noteworthy, disease suppressive relationships of ROR2 have been 
described in hepatocellular cancer, colon cancer and hematological malignancies [58, 59, 66, 
67]. The canonical Wnt pathway has a pro-tumorigenic effect, leading to a series of cellular 
processes including proliferation, differentiation, polarity, migration, invasion, adhesion and 
survival [68, 69]. Through inhibiting this canonical Wnt signaling as a gatekeeper, ROR2 has 
been proposed to play a role in tumor suppression [68]. However, further studies will be 
required to clarify the exact molecular mechanism caused by down-regulation of ROR2 
expression in IH development. 
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Table S1 ROR2 primers for PCR and Sanger sequencing 
Primer name 5´- 3´ Product size (bp) 
ROR2_Ex1fwd CGAAAGGGACCAACTTGCCA 282 
ROR2_Ex1rev CATCGCGAGGGAAGGGACG  
ROR2_Ex2fwd GGGCAGTTTTGCTAAAACACTAT 300 
ROR2_Ex2rev GGGAGACCCTGACCATCCAT  
ROR2_Ex3fwd GTGGTGGAGGCAACATTCTA 617 
ROR2_Ex3rev TCATGCACAATGGGAAAGGC  
ROR2_Ex4fwd CAGAGAGCACCCCTTCCATC 370 
ROR2_Ex4rev TGCCATCCCTGTGTGAAGTC  
ROR2_Ex5fwd GCCAAGGGACAAGATGGCTA 330 
ROR2_Ex5rev GGGACAAAATACACAAATGAGACTG  
ROR2_Ex6fwd CAGTTGCAAATCTGGGCGG 668 
ROR2_Ex6rev GAATGGAGCGGGTCTGTG  
ROR2_Ex7fwd TGGCGAGGTGGTTTGGTTAT 479 
ROR2_Ex7rev ATGGTGGTGAAACACGGTGG  
ROR2_Ex8fwd AGTTGGAGGTGGGAGTGGGC 346 
ROR2_Ex8rev GTAGAGGTTAAGCCTGGGGG  
ROR2_Ex9.1fwd CCGCCCAACCCCTTCTCC 552 
ROR2_Ex9.1rev GGCCAGGTCTTTGTGGACCA  
ROR2_Ex9.2fwd GGCATGGAGTACCTGTCCAG 965 
ROR2_Ex9.2rev GTCTCAGGGACTGAGCCG  
ROR2_Ex9.3fwd CTCCCATCACAGCGGCAGCG 399 
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Ribosomal protein L11 is a member of the 80S core ribosomal proteins encoded by the 60S 
ribosomal protein L11 gene. Due to its role in ribosome biogenesis and that it has been 
associated with fatal ribosomopathies, we addressed the question whether lethal uL5 variants 
exist in cattle. Several deleterious variants have been deposited including a two base pair 
deletion (rs381576999) resulting in a frameshift and premature stop. A probe for this variant 
had been included as expert-selected marker in the custom add-on part of the BovineLD 
BeadChip and can therefore be monitored during routine genotyping. To determine the 
frequency of the variant, we genotyped 370,527 cattle, including 18 different dairy and beef 
cattle breeds. 299,218 homozygous wild type and 71,249 heterozygous cattle were called from 
the bead chip. Cattle harboring the homozygous mutant genotype were not detected. According 
to Hardy-Weinberg equilibrium 4,241 homozygous individuals carrying the deletion should 
have been present in the cohort. Hence, the data apparently indicated that the homozygous 2 bp 
deletion in uL5 is a lethal variant interfering with ribosome biogenesis. An attempt to verify the 
deletion in randomly chosen cattle with heterozygous calls using Sanger sequencing failed to 
detect the putative deletion. An alignment of the BeadChip probe to the bovine genome showed 
a perfect match to a processed uL5 pseudogene on bovine chromosome 18 mimicking the 
assumed exonic deletion. The analysis shows how processed pseudogenes may confound 
quantitative results depending on the placement of probes in a particular assay design resulting 
in false results. 
 
Key words: Ribosome biogenesis, ribosomal protein, RPL11, uL5, processed pseudogene, 
ribosomopathy, Diamond-Blackfan anemia, embryonic lethal 
 
Ribosomes are large RNA-protein complexes that catalyze protein synthesis either linked to the 
endoplasmic reticulum or in the cytosol. Eukaryotic ribosomes consist of a large 60S (LSU) 
and a small 40S (SSU) subunit. For protein synthesis both subunits are assembled into the final 
80S ribosome containing more than 5500 nucleotides of rRNA, 80 core ribosomal proteins (RP) 
and more than 150 associated proteins in higher eukaryotes [1, 2]. Several external and genetic 
factors result in ribosomal stress and impairment of ribosome biogenesis leading to 
accumulation of ribosome-free forms of RPs [3]. Impaired ribosome biogenesis and function 
can result in specific clinical phenotypes the so-called ribosomopathies [2]. In humans at least 
six ribosomopathies have been described, i.e. Diamond-Blackfan anemia (DBA), 5q-syndrome, 
Shwachman-Diamond syndrome, X-linked dyskeratosis congenita, Treacher Collins syndrome 
and cartilage hair hypoplasia, most of them also associated with an increased cancer risk [2, 4]. 
DBA belongs to a rare group of disorders known as inherited bone marrow failure syndromes 
[5]. It is a genetically heterogenous disorder caused by variants in 20 different ribosomal genes 
resulting in distinct clinical phenotypes (DBA1-20) [2]. In humans, DBA7 is caused by variants 
of the 60S ribosomal protein L11 gene (uL5, formerly RPL11) and is inherited mainly 
autosomal dominantly although autosomal recessive inheritance has also been reported [6-8]. 
Patients with uL5 deficiency show cleft lip and/or palate and isolated thumb abnormalities [2, 
9, 10]. So far naturally occurring uL5 defects have only been described in humans. An inducible 
Rpl11-null allele has been introduced in mice demonstrating that a single gene dose is 
Processed pseudogene confounding the presence of a putative lethal recessive deletion in 
the bovine 60S ribosomal protein L11 gene (uL5) 
 
 98 
insufficient to support embryonic development. Homozygous deletion of Rpl11 is lethal within 
a few weeks due to bone marrow aplasia and intestinal atrophy [11]. Rpl11 deficiency has also 
been studied in a zebrafish model for DBA [12, 13]. 
Despite the obvious importance of ribosome biogenesis for viability, ribosomopathies have not 
been described in cattle so far. Therefore, we were interested whether lethal variants exist in 
bovine ribosomal protein genes. Similar to the identification of the lethal haplotypes in several 
important cattle breeds, we hypothesized that the complete absence or statistically significant 
underrepresentation of a homozygous mutant genotype in the population is indicative for a 
lethal defect [14-17]. Depending on the genotype frequency of homozygous wild type and 
healthy heterozygous carriers this defect will actually be embryonic lethal. Due to the severe 
effects of uL5 mutations in humans and lethal effect in mice we decided to analyze bovine uL5. 
In exon 3/4 of the bovine uL5 gene located on chromosome 2 a deletion of two base pairs has 
been deposited into bovine genomic databases, which would result in a frameshift and a 
premature stop codon (ENSBTAG00000020905:g.129,195,922_129,195,923del; ARS-
UCD1.2; rs381576999). The deletion causes a truncation of uL5. To monitor this variant a 
probe located on BTA2 between position 129,195,924 to 129,195,973 (ARS-UCD1.2) was 
included on the BovineLD BeadChip (Illumina) (Fig. 1). High-throughput genotyping was 
performed on a HiScanSQ and/or iScan System (Illumina). Raw data were converted using 
GenomeStudio 2.0.4 Software (Illumina). Cattle blood samples were drawn by local 
veterinarians. The collection of samples was approved by the Lower Saxony State Office for 
Consumer Protection and Food Safety (33.19-42502-05-17A196) according to §8a Abs. 1 Nr. 
2 of the German Animal Protection Law. 
The presence of the deletion was validated in a total of 370,527 cattle. 299,218 homozygous 
wild type and 71,249 heterozygous cattle were detected. No homozygous carriers were 
identified resulting in highly significant deviation from HWE (𝝌2= 4,193.4) [18]. The observed 
cluster separation and GC-scores of the uL5 SNP were sufficiently high to exclude any technical 
bias by the chip-based genotyping method as confounding factor. If the deletion would not have 
a lethal effect approx. 4,241 homozygous carriers would have been expected according to 
HWE. In contrast to the DBA mouse model heterozygous carriers seemed to be healthy, as we 
did not have any reports on phenotypical abnormalities in cattle of the heterozygous cohort. As 
the deletion was detected in at least 18 different dairy and beef cattle breeds that were within 
the genotyped cohort, i.e. British Angus, Charolais, Braunvieh, Belted Galloway, Simmental, 
Dexter, German Black Pied cattle, Gelbvieh, Hereford, Limousin, Red Holstein, German Red 
cattle, Holstein, Shorthorn, Uckermärker, Wagyu, Welsh Black cattle and Belgian Blue, it must 
have been introduced into the cattle population early in domestication. In respect to the deduced 
rather high allele frequency of 0.11, it was quite astonishing that abnormal cattle have never 
been noticed so far. We therefore decided to verify the deletion by Sanger sequencing in cattle 
that had been genotyped as being heterozygous. For PCR and Sanger sequencing primers were 
designed based on the bovine reference sequence ARS-UCD1.2 using Primer3 [19] to 
specifically amplify the genomic region of rs381576999. PCR was performed in a total volume 
of 25 μl, including 1× PCR reaction buffer plus 20 mM MgCl2, 0.5 μl of 10 mM dNTPs, 1 U 
FastStart Taq Polymerase (Roche), 1 μl of 10 pmol/μl each primer (uL5_Ex4_for: 5´-
AGAGCGGGAGTGGGAGACTCGGT-3´; uL5_Ex4_rev: 5´-
TGGGGGTCTTGAGTGTTGCAGGCT-3´), and 1μl of 20 ng/μl DNA. Reaction conditions 
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included 95 °C for 10 min, then 30 cycles of 95 °C for 30 s, primer-specific annealing 
temperatures for 30 s and 72 °C for 45 s, followed by final elongation at 72 °C for 7 min. The 
purification of the PCR products was performed using Rapid PCR Cleanup Enzyme Set (New 
England Biolabs GmbH, Germany). Subsequently sequencing was realized using the BigDye 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Thermo Fisher Scientific GmbH, 
Germany) and products were analyzed on an ABI PRISM 3130xl Genetic Analyzer (Life 
Technologies, USA) following the manufacturer´s protocols. Sequencing primers were 
identical to PCR primers. Identification of nucleotide polymorphisms via sequence alignments 
was realized using Sequencher 5.4.6 (Gene Codes, USA). None of the randomly selected 
heterozygous cattle identified by genotyping using the BeadChip were proved to be carriers of 
the putative deletion (Fig. 1). An alignment of the BeadChip probe to the bovine genome 
revealed an almost perfect match (49/50 nucleotides) to a processed uL5 pseudogene on BTA18 
(LOC112442347; position 54,982,088 to 54,982,687) harboring the reported 2 bp deletion in 
uL5. We therefore designed amplification primers for the putative binding region of the probe 
on the pseudogene and sequenced the previously detected heterozygous cattle. As shown in Fig. 
1 the analyzed cattle were homozygous for the 2 bp deletion within the pseudogene. The 
genotyping results were clearly confounded by the erroneous detection of this variant. Our data 
demonstrate how pseudogenes can lead to severe misinterpretations when using high 
throughput genotyping platforms without knowing the assay design. Therefore, special care 
should be taken when designing probes and/or primers for a specific assay to accomplish 
accurate results that can be used in breeding programs. 
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Fig. 1 Alignment and DNA sequencing of a putative 2 bp deletion in uL5 and comparison 
with a processed uL5 pseudogene (LOC112442327) 
The figure depicts the alignment of uL5 (BTA2) with the BovineLD BeadChip probe and the 
processed uL5 pseudogene (LOC112442327) (BTA18) between the indicated positions (ARS-
UCD1.2). The putative 2 bp deletion (rs381576999) is underlined and bold. The upper and 
lower chromatograms show the local sequences flanking rs381576999 (uL5) and the 
homologous region on BTA18 of the same individual. At both locations the individual is 
homozygous wild type resulting in an erroneous heterozygous genotype at uL5. 
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In this thesis analyses were performed to elucidate potential pathological genetic aberrations of 
osteogenesis imperfecta and interdigital hyperplasia in HF cattle, as well as ribosomopathies in 
18 different dairy and beef cattle breeds. 
1 Significance of the research study 
The first question underlying this dissertation can be stated as “What is the genetic cause of the 
lethal case of OI in HF?”. In humans the OI-related molecular mechanism has been clearly 
explored (see General Introduction 1.3.1). Cases of OI in HF cattle have also been reported 
since 1983 [1, 2]. The identification of their causative mutations would be of great importance 
for cattle healthiness and breeding improvement. However, it has been challenging in the past 
decades to elucidate the causative mutation of OI in HF, which might imply a more complicated 
OI genetic cause in cattle than in humans. 
 
The second question in this dissertation comprises “What is the molecular cause of IH in HF?
” and “Does a major-effect gene exist in IH development?”. Claw disorders are recognized 
as an important animal welfare problem at dairy farms causing serious economic losses. Hoof 
health has been included as an important trait in dairy cattle breeding. The recently updated 
breeding value evaluation for Holsteins covers the whole range of important traits including 
mastitis resistance, reproduction, metabolic stability, health as a total trait as well as hoof health 
[3]. IH as a common foot disease shows a rather high estimated heritability (see General 
Introduction 2.2.4). Elucidation of the potential genetic cause of IH risk is of great importance 
contributing to future practical breeding for better hoof health. 
 
The third question in this dissertation was “Do lethal variants exist in the causal genes of 
ribosomopathies in cattle?”. Ribosome biogenesis plays fundamental roles in cellular 
development. Its functional impairment contributes to embryonic lethality and tumorigenesis 
[4, 5]. In humans a list of ribosomopathies have been described, with the causative mutations 
reported (see General Introduction 3.2). The identification of developmentally lethal recessive 
variants in these causal genes has potential significance to reduce the incidence rate of 
embryonic loss/lethality in cattle breeding. 
2 Evolutionary genetic dissection technologies 
The rapid development of technologies, e.g. DNA chip, NGS, advanced statistical models, has 
not only driven discoveries in monogenic disorders but also accelerated genetic dissections of 
complex traits [6]. However, every technology carries advantages and disadvantages. It is of 
importance to know their features, limitations and the fitness for their potential applications. 
2.1 Genome-wide association study 
GWAS is a powerful and popular tool for the dissection of genetic diseases. It provides a 
hypothesis-free way that systematically tests hundreds of thousands or even more variants in 
the whole genome without priorly knowing the position of the causal gene/variant [7]. To date, 




GWAS can produce meaningful results of positive associations depends on a plethora of 
parameters, e.g. selection of cases/controls, phenotype, and available sample size [6]. In 
Chapter 3 of this thesis, a herd with extreme prevalence of IH was genotyped using the 
BovineSNP50 BeadChip and subsequent GWAS successfully identified a significantly IH 
associated chromosomal region. In Chapter 2 of this thesis, GWAS detected six significantly 
associated SNP loci, implying a more complicated molecular background of OI in Hostein 
cattle than the monogenic OI in humans. In addition, GWAS is designed to detect small variants 
like SNPs and small InDels, but it is difficult to identify an associated region, if the causative 
mutation is a large structural variant. Besides, BeadChip can be used for high throughput 
genotyping purpose. In Chapter 4 of this thesis, our data demonstrate how pseudogenes can 
lead to severe misinterpretations when using high throughput genotyping platforms without 
knowing the assay design in the BeadChip. Therefore, it is very important to take special care 
when designing probes and/or primers for a specific assay to accomplish accurate genotyping 
results. Compared to custom BeadChips, a sequence-called genotyping assay would be more 
reliable to accomplish accurate results. 
2.2 NGS-based analysis 
Efficiency of DNA sequencing has developed tremendously in recent years [8]. NGS 
technology with massively parallel processing can be applied flexibly for whole genome 
sequencing from small genomes like viruses or bacteria to complex genomes like animals and 
plants. Its application ranges from exome and metagenome, to transcriptome, also to analysis 
of DNA-protein-interactions and methylation sequencing. On a genomic level, mutations can 
be divided into two major categories, single nucleotide polymorphisms (SNPs) and structural 
variants (SVs). 
2.2.1 Single nucleotide polymorphisms 
A comprehensive and efficient SNP-based analysis of NGS data contains three mapping 
strategies, i.e. rare recessive homozygous polymorphisms, de novo candidate and compound 
heterozygous polymorphisms, to identify causal genes/SNPs of monogenic disorders. Large-
scale genotyping is crucial to validate potential causative SNPs. High-resolution melting curve 
analysis can be applied efficiently for large-scale studies including FRET, TaqMan assay, 
ARMS, RFLP and so on. For instance, in Chapter 2 of this thesis, PCR-RFLP, ARMS and 
multiplex-FRET-PCR were performed to validate the variants rs209568970 in IFITM5, 
rs209556962 in QRFPR, as well as rs381405831 and rs110593220 in ABCA13, respectively, in 
a large-scale cohort of healthy control animals. In Chapter 4, FRET was also designed to test 
the 2bp-deletion (rs381576999) in RPL11 in 370,527 cattle. These techniques were proven to 
be very time saving. 
2.2.2 Structural variants 
The combination of NGS and sophisticated computational tools have been developed to detect 
somatic SVs from the massive amount of raw sequencing data. Each computational method has 
its own unique characteristics, e.g. focusing on certain types of SVs, read mapping or clustering 
strategy, as well as the use of split reads and/or discordant read pairs [9]. In the OI study of this 




most basic SV types were detected, i.e. deletion, insertion, duplication, inversion and 
translocation. However, validation by Sanger sequencing showed that the predictions were 
misled by repetitive elements from different chromosomes. Therefore, whether repetitive 
elements exist should be considered to interpret SV prediction results. In addition, the following 
aspects should be considered for accurate and complete detection of SV [9]. Longer read-length 
sequence data with lower error rates can improve the capacity in SV detection. Uniform 
coverage across the genome is also important, since non-uniform coverage can cause substantial 
difficulties for SV detection in regions with low coverage. Diverse combinations of the same 
or different SV types lead to more complicated chromosomal rearrangement events, which can 
be hard to detect and validate. It is necessary and crucial to develop rules and standards to 
compare the results from different programs. Besides, dosage-variant DNA copy number 
variation, a subtype of SVs, also needs to be considered [9]. 
2.3 Functional effect validation of novel variants 
When a potential causative mutation is identified, it is crucial to validate its functional effect. 
Functional experiments are also effective to exclude nonfunctional variants. To substantiate the 
pathogenicity of a novel variant, both in vitro and in vivo experiments are robust approaches. 
Compared to in vivo test in regard to expenditure of time, in vitro characterization of a novel 
variant should be preferably undertaken to verify its impact on protein stability, structure, and 
function. Deleterious exonic variants could induce protein conformational changes, affecting 
protein folding, protein interactions with other proteins as well as stability or solubility of 
protein molecules. Exonic variants, especially variants in signal peptides, could also lead to 
changes in gene expression level and mRNA stability. Deleterious variants in transcriptional 
regulatory elements, i.e. promoter, activator, enhancer and silencer, could result in altered gene 
expression level. Additionally, the production of animal models can be used. However, both 
methods are time-consuming, labor-intensive, technically difficult and expensive. Therefore, 
prior to functional validation, prediction of the potential functional effect of a novel variant is 
necessary using computational tools. 
3 Cattle as an animal model to study claw disorders 
Mice are popular as an animal model to study genetic disorders like osteogenesis imperfecta 
and ribosomopathies, because of their genomes similar to that of humans, low cost, little size, 
fast reproduction rate and ease of handling [12]. Other common animal models include zebra 
fish, fruit flies, worms, and chicken [12]. Claw disorders mainly cause detrimental impacts on 
large livestock. In additional to cattle, they have also been reported in buffalo, sheep and goat. 
Foot diseases would better studied in dairy cattle as the more suitable animal model, compared 
to these little size animals. Early in 1989, Harper et al. employed bovine models to study 
citrullinemia, a urea cycle genetic disorder characterized by hyperammonemia [13, 14]. A 
distinct advantage of bovine models is that they manifest well the clinical signs of claw 
disorders, since livestock have the largest body size. Also, claw disorders are common in dairy 
cattle with a rather high prevalence, which easily brings them to the attention of veterinary and 
research communities. In addition, the availability of extensive recording of phenotype, well-




to quickly dissect the genetic architecture in cattle [15]. Most importantly, body size, body 
weight, herd size, poor hygiene, rocky pastures etc. are crucial factors to trigger a genetic 
predisposition in IH development [16, 17]. While traditional lab-based animal models are likely 






Conclusions and Outlook 
From the results of the three subprojects on cattle genetic diseases (osteogenesis imperfect, 
interdigital hyperplasia and ribosomopathies), the following interpretations and conclusions can 
be derived for future investigation: 
 
Study 1: Osteogenesis imperfecta in an embryo transfer Holstein calf 
• OI has severe and even lethal impacts in humans and animals. The OI-related molecular 
mechanism in humans has been clearly explored, with a series of candidate genes 
reported. OI cases in HF cattle have been reported since 1983. However, no causative 
mutations have been identified to date. 
• The analysis of the OI case reveal an oligogenic origin of the disease. A haplotype of 
four potentially functional variants in three candidate genes (ABCA13: 
ENSBTAT00000061018.2:c.12553+1A>G, ENSBTAP00000034167.5:p.Gln4307Arg; 
QRFPR: ENSBTAP00000010865.4:p.Arg412Ter; IFITM5: 
ENSBTAP00000041562.3:p.Ala30Ser) is most likely leading to the development of OI 
in the affected calf with a detrimental additive effect. 
• An oligogenic inheritance should also be considered for the OI development in HF 
 
Study 2: Interdigital hyperplasia in Holstein cattle is associated with a missense mutation in the 
signal peptide region of the tyrosine-protein kinase transmembrane receptor gene 
• Interdigital hyperplasia very likely only causes harmful impacts on large livestock. Hoof 
health has been included as an important trait in dairy cattle breeding, from the 
perspectives of both economic and animal welfare. 
• Genetically, interdigital hyperplasia is significantly associated with the missense 
mutation in the signal peptide region of ROR2 (NC_037335.1g.85905534T>A; 
rs377953295; ARS-UCD1.2). Genotyping and association analysis suggest that the A-
allele at rs377953295 could be detrimental and associated with an increased risk to 
develop IH. 
• This variant results in an amino acid exchange (ENSBTAP00000053765.2:p.Trp9Arg) 
in the N-terminal region of the ROR2 signal peptide which is necessary for proper 
topology of the polypeptide during translocation. Quantification of ROR2 mRNA and 
ROR2 protein shows that the variant results in a significant suppression of ROR2 
expression in homozygous affected compared to wild type and carrier cows. 
• ROR2 expression in hyperplastic compared to normal interdigital skin also shows a 
significant reduction which explains the observation that hyperplastic skin alterations 
are also present in T_T or A_T cattle. 
• The biological function of ROR2 in the molecular mechanism of IH development is still 
unclear. The down-regulation of ROR2 in mutated cattle might be explained by a 
general mechanism of transcriptional quality control. Previous reports also gave some 
clues to what could cause the down-regulation of ROR2 in hyperplastic interdigital skin, 
especially in wild type cattle. Also, further studies will be required to clarify the 
molecular mechanism caused by the down-regulation of ROR2 expression in IH 




• Cattle should be considered as an animal model to study claw disorders, instead of other 
animal models. 
 
Study 3: Processed pseudogene confounding the presence of a putative lethal recessive deletion 
in the bovine 60S ribosomal protein L11 gene (uL5) 
• So far no lethal recessive variants of ribosomopathies have been detected in cattle. The 
putative lethal recessive deletion in the DBA causal gene RPL11, was confounded by 
the processed pseudogene and actually does not exist. 
• By identifying haplotypes for which homozygotes are not present but would be expected 
based on genotype frequencies and HWE, developmentally lethal recessive variants can 
be determined. 
• Compared to custom BeadChips, a sequence-called genotyping assay would be more 
reliable. Pseudogenes can lead to severe misinterpretations when using high throughput 
genotyping platforms without knowing the assay design. 
• In practical breeding, through targeted matings with non-carriers, a potential identified 
detrimental allele should be excluded to mitigate/remove the defects or embryonic 
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